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ABSTRACT 
High salt diet-induced alteration in vascular reactivity in wild-type and adenosine 
A2A receptor null mice 
 
Isha Pradhan 
Alteration in vascular reactivity serves as a marker for cardiovascular disease. 
Enhancement of vasodilatory response through adenosine A2A receptor (A2AAR) signaling 
against high salt (HS) diet is speculated to be an adaptive response as salt-sensitive rats 
showed upregulation of A2AAR and cyp-epoxygenases but salt-resistant rats did not. 
However, no direct evidence is available showing the compensatory role of A2AAR 
signaling upon salt loading. For this, understanding the functional and biochemical 
outcome of HS diet on vascular tone regulation and its underlying signaling mechanism 
in the presence and absence of A2AAR is required. This dissertation was carried out to 
investigate the role of A2AAR and epoxyeicosatrienoic acid (EETs) on HS-modulated 
vascular reactivity and its signaling pathway involved using A2AAR+/+ and A2AAR-/- mice. 
Isometric tension measurement and western blot studies were conducted to evaluate 
aortic reactivity and underlying signaling mechanism in HS and normal salt (NS) fed 
A2AAR+/+ and A2AAR-/- mice. Our data demonstrated clear differences in vascular 
reactivity and their signaling mechanism between A2AAR+/+ and A2AAR-/- mice on a HS 
diet. HS diet enhanced vascular relaxation to adenosine in A2AAR+/+ mice, while HS diet 
amplified contraction to adenosine in A2AAR-/- mice. In the presence of A2AAR, we found 
that enhanced vascular relaxation to HS is mediated through A2AAR coupled with EETs 
that activate peroxisome proliferator activated receptor-gamma (PPARγ) leading to 
opening of ATP-sensitive K+ (KATP) channels downstream. In contrary, in the absence of 
A2AAR, HS-elicited amplified contraction is found to occur through loss of vasodilatory 
response and its signaling involving EETs and PPARγ and increased vasoconstrictors 
such as adenosine A1 receptor (A1AR) and soluble epoxide hydrolase (sEH), an enzyme 
that degrades EETs. Most importantly, our finding revealed that increasing EETs 
availability through sEH inhibition could be a potential strategy to improve exaggerated 
vascular contraction in HS-fed A2AAR-/- mice. 
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CHAPTER ONE: 
 
INTRODUCTION 
 
 High dietary salt is widely associated with increase in blood pressure (BP) (85) and other 
cardiovascular diseases (1, 9, 43). Around half of individuals with essential hypertension are 
salt-sensitive (107); that is, they are particularly susceptible to the effects of salt on BP. Salt 
sensitive hypertension (SSH) refers to dramatic changes in blood pressure with corresponding 
changes in salt intake (77). BP response to high salt diet is heterogeneous mainly because of 
the complexity of causal factors, meaning they arise from combined action of many genes, 
age, race/ethnicity, environmental factors, risk conferring behaviors as well as disease states 
such as renal dysfunction and diabetes. More than ever, the demand and relevance for research 
on salt-induced hypertension is exceedingly greater because of an ever growing inclination 
towards the excess consumption of processed food highly loaded with salt. Although the 
pathophysiological mechanisms leading to salt sensitivity are complex and only partially 
understood, it appears that some of the determinants of salt sensitivity include altered renal 
vascular and tubular function, impaired renin-angiotensin-aldosterone system, atrial 
natriuretic peptide, genetic polymorphism, and vascular dysfunction (107).  
 
Renal vascular and tubular function plays an important role in salt and water regulation. 
Vasomotor tone regulation is influenced by complex intrinsic and extrinsic factors; where 
extrinsic control includes neurohormonal regulation from outside of vessels and intrinsic 
control includes myogenic, endothelial dependent (NO, endothelin, EDHFs), local mediators 
(histamine, bradykinin, prostaglandin) and metabolic regulation (adenosine, H+, K+, CO2) of 
vessel wall. Chronic salt consumption increases cardiovascular morbidity and mortality both 
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by its influence on BP regulation and by pressure-independent effects on the blood vessels 
and heart. Human studies have shown that HS-diet intake can impair vascular and cardiac 
function in normal healthy subjects independent of changes in BP (28, 31, 103). These studies 
are of great significance as endothelial dysfunction, represented by reduced flow-mediated 
dilation and impaired acetylcholine-dependent vasodilation has been shown as a predictive 
marker of vascular events such as myocardial infarction and stroke. HS diet has been 
demonstrated to alter vascular tone in renal pre-glomerular microvessels (PGMVs) and aorta 
(58, 71). Of particular interest to this work, role of adenosine and arachidonic acid metabolite 
of cyp-epoxygenase, EETs, have been implicated in HS diet-induced modulation of vascular 
tone (19-20).  
Adenosine: 
Adenosine, a breakdown product of adenosine triphosphate (ATP), is an endogenous 
nucleoside that exerts several physiological and pathophysiological effects. Chemical 
structure of adenosine is depicted below in Fig.1.1. Adenosine can be formed by hydrolysis of 
either adenosine monophosphate (AMP) or S-adenosylhomocystiene. Ecto-5’-nucleotidase 
hydrolyze adenosine monophosphate (AMP) to adenosine (73). In addition, adenosine can 
also be synthesized by the action of S-adenosylhomocystiene hydrolase (SAH) on S-
adenosylhomocystiene (88). Upon entering the circulation, adenosine is metabolized to 
inosine by adenosine deaminase present in red blood cells and vessel wall and finally is 
broken down to uric acid, which is excreted in urine. The synthesis and metabolism of 
adenosine inside and outside of cell has been shown Fig 1.2 (40). Once adenosine exits 
outside of cells in extracellular space, it acts on adenosine receptors and exerts various 
physiological effects. 
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  Adenosine mediates its various physiological effects through activation of four different 
purigenic receptors: A1, A2A, A2B, and A3. All the four receptors are G-protein coupled with 
seven transmembrane domains (37). Each of these receptors has their own pharmacological 
profile, tissue distribution, affinity to adenosine and effector coupling. They are classified on 
the basis of their ability to activate or inhibit adenylyl cyclase (AC) and regulation of cyclic-
adenylyl monophosphate (cAMP) levels. A1 and A3 receptors are coupled to Gi whereas A2A 
and A2B receptors are coupled to Gs (37). A1 receptor coupled with Gi/o G-proteins when 
stimulated cause inhibition of AC leading to decrease in cAMP levels (37). Activation of A1 
receptor can also lead to induction of IP3/DAG through PLC pathway (99). A1 receptors are 
involved in water and salt retention, lowering of heart rate, mediating tubuloglomerular 
feedback, vasoconstriction, and inhibition of sympathetic neurotransmission (10, 64, 97, 101, 
106). A2A receptor coupled with Gs G-proteins when stimulated cause activation of AC leading 
to increase production of cAMP levels (37). Effects of A2A receptor activation include 
vasodilation (41), and anti-inflammation (102). A2B receptors signal through Gs/q meaning its 
activation either result in stimulation of AC to produce cAMP or stimulation of IP3/DAG to 
increase Ca2+ levels. Finally, A3 receptor signals through Gi that inhibits AC and cAMP 
production (37).  
 
 
 
 
 
 
  
 
 
 
 
                                       Figure 
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1.2: Adenosine formation and metabolism  
Figure 1.1: Structure of Adenosine 
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Adenosine and high salt diet: 
Adenosine mediates several physiological effects that are cytoprotective in nature among 
which its effect on vasculature is crucial for vasoregulation (42) and physiological control of 
BP (2, 54). It is generally produced in response to stressful conditions such as hypoxia, 
ischemia and injury in cells to repair damage (59). HS diet also elicit stressful effects that 
elevates adenosine concentration because switching rats from NS to HS diet leads to increased 
adenosine levels in the renal cortex and medulla and increased urinary adenosine levels (90). 
In addition, ecto-5’-nucleotidase activity that convert AMP to adenosine has also been 
reported to augment in response to high salt diet (87). This implies excess salt consumption 
can elevate adenosine generation possibly by augmenting ecto-5’-nucleotidase activity. 
Mounting evidence suggests a link between HS intake and activation of A2AAR in particular 
in renal medulla, pre-glomerular microvessels and aorta in rodents (30, 71, 118), indicating 
that this phenomenon is not limited to kidneys but also extends to larger vessels like aorta. 
 Vasodilator, A2AAR, has been demonstrated to upregulate with high dietary salt (58, 71). 
While A1AR, responsible for vasoconstriction, is shown to decrease in HS-treated animals (81, 
91, 118). Thus, through the activation of A2A receptors, increased renal adenosine levels could 
contribute to dilation of PGMVs, and the inhibition of tubular sodium reabsorption (62, 94), 
leading to enhanced sodium excretion to maintain the constancy of body fluid volume and 
arterial pressure (8, 94). Moreover, compared to NS-diet, HS-diet treated animals showed 
enhanced vasodilation through A2A receptors (58, 71). Therefore, these data demonstrating 
enhancement of A2AAR-mediated vasodilation in response to salt loading in different 
vasculature supports the correlation between A2AAR and excess salt intake.  In contrast, 
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stimulation of A1 receptors produces pre-glomerular vasoconstriction, activation of 
tubuloglomerular feedback response, reduction in renin release leading to reduction in sodium 
excretion (76, 94).  Important study by Liclican et al. (57) showed the critical difference 
between HS-fed Dahl salt-sensitive and Dahl salt-resistant rats in terms of A2AAR expression 
in renal PGMVs. When placed on seven days HS diet, Dahl salt–resistant rats showed 
upregulation of A2AAR and BP remained normal while, Dahl salt-sensitive rats failed to 
upregulate A2AAR and developed salt-sensitive hypertension. This finding points out to the 
potential adaptive role of A2AAR in the maintenance of BP in response to salt loading. This 
study, however, is indirect and more concrete evidence is required to support this idea.  Hence, 
this dissertation project discussed here focuses on addressing this limitation by using A2AAR 
wild type and A2AAR deficient mice on a high salt diet for 4 weeks. 
Arachidonic acid-derived metabolites: 
Arachidonic acid (AA) is a 20 carbon polyunsaturated fatty acid stored within phospholipid of 
cell membrane in resting cells. A receptor dependent activation of G-coupled protein initiates 
phospholipid hydrolysis and releases the fatty acid. AA can be hydrolyzed and freed from 
phospholipid by two enzymes: phospholipase A2 (PLA2) and phopholipase C (PLC). PLA2 
directly cleaves off AA. In contrast, PLC catalyzes the hydrolysis of AA by first generating 
diacylglycerol (DAG), which then is subsequently cleaved by diacylglycerol lipase liberating 
AA (12). Once, released in the cytosol, AA is involved in cellular signaling as a second 
messenger playing a role in regulation of different signaling enzyme, inflammation and 
vasodilation. Three distinct enzymes can metabolize free AA: cycloxygenase (COX), 
lipoxygenase (LOX) and cytochrome p450 (CYP450) epoxygenase. Arachidonic acid-derived 
metabolites catalyzed by COX and LOX are prostaglandins and leukotrienes, respectively. 
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These metabolites play an important role in renal and pulmonary functions, regulation of 
inflammation and vascular tone (23, 83).  
Capdevila et al. (17) reported that AA is metabolized by the third group of enzyme called 
cytochrome P450 that is divided into two major subtypes: Cyp450-epoxygenases (cyp-
epoxygenases) and omega-hydroxylases (ω-hydroxylases) shown in Fig. 1.3.  Cyp-
epoxygenases convert AA into epoxyeicosatrienoic acid (EETs) (67) which is primarily 
degraded into more soluble metabolite dihydroxyeicosatrienoic acid (DHET) by soluble 
epoxide hydrolase (sEH). Figure 1.4 demonstrates the EETs formation and degradation 
pathway (6). EETs can also be metabolized by ω-oxidation, β-oxidation, and chain elongation; 
these metabolic pathways become prominent when sEH activity is low or inhibited (20). 
Major isoforms of cyp-epoxygenase enzyme are cyp2c and cyp2J. Cyp-epoxygenase isoforms 
are species specific where cyp2c8, cyp2c9 and cyp2j2 are in humans, cyp2c11, cyp2c23, and 
cyp2j3 are in rats and csyp2c40, cyp2c44, cyp2c29 and cyp2j5 are in mice (36). On the other 
hand, ω-hydroxylase converts AA into hydroxyeicosatetraenoic acid (19 and 20-HETE) (18). 
Main pathway of 20-HETE breakdown is by β-oxidation to shorter less active products. Major 
isoform of ω-hydroxylases includes cyp4a and cyp4f present in liver, kidney, lung, brain and 
vasculature. 
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Figure 1.3: The enzymatic pathway of AA producing EETs and HETEs 
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Figure 1.4:  The enzymatic pathway of EETs production from AA and EETs degradation by 
sEH  
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Effects of EETs and HETEs:  
EETs and HETEs exhibit variety of biological effects. EETs play a critical role in renal, 
pulmonary and cardiac function and vascular tone (83). EETs primarily act as paracrine and 
autocrine effectors that produce anti-inflammation and anti-thrombosis actions (93). In 
vasculature, cyp-epoxygenases enzymes are present in endothelial cells. In variety of species, 
EETs are known to increase blood flow through vasodilation of coronary, renal and cerebral 
vascular beds (32, 39, 49, 79). The EETs are endothelial derived hyperpolarizing factors 
(EDHFs) (15) that regulate ion channels to cause vascular relaxation (67-68). Accumulating 
evidence shows that EETs activate BK channel in smooth muscle cells (56). Some reports 
have also revealed that KATP channels are involved in EETs-mediated vasodilation (80). In 
contrast, 20-HETE plays an important role in tubuloglomerlar feedback, renal autoregulation 
and vasoconstriction (63, 69, 117). It is a potent vasoconstrictor that is formed upon 
stimulation of angiotensin II, endothelin and serotonin (5-HT). Increased levels of 20-HETE 
are shown to promote vasoconstriction that contributes to the progression of hypertension (38, 
105). 20-HETE activates L-type Ca2+ channel and inhibits BK channel leading to sustained 
depolarization of vascular smooth muscle cells (53, 96, 116). In general, EETs and 20-HETE 
exert opposing effects in vascular tone regulation. 
High salt diet and cytochrome P450-derived metabolites of Arachidonic Acid: 
Apart from adenosine, cyp450 enzymes and their AA-derived metabolites are also associated 
with HS-diet. In kidney, dietary salt intake is documented to regulated renal cyp-
epoxygenases (19). HS induced marked increase in cyp-epoxygenases isoforms (114), 
epoxygenases activity (75) and increase the urinary output of AA-derived metabolites through 
cyp-epoxygenases as well. Makita et al. (65) demonstrated that HS diet by itself did not 
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increase blood pressure but dietary salt intake did increase BP in rats upon the inhibition of 
cyp-epoxygenase with clotrimazole, thus rendering the rats salt-sensitive. Along these lines, 
decreased cyp-epoxygenases activity, blockade of EETs formation, and impaired vasodilation 
are coupled with salt-induced hypertension (19, 114). Hence, evidence from these studies 
suggests a key role of an inducible cyp-epoxygenases and their metabolites in compensatory 
renal response to salt loading that may protect against hypertension.  
High salt diet, adenosine and EETs: 
The linkage of HS diet with A2AAR activation as well as with cyp-epoxygenases activity was 
discussed earlier. Cheng et al, 2004 established a connection between vascular A2AAR 
activation and increased cyp-epoxygenases activity in rat PGMVs (22). A2AAR and AA-
derived metabolites (EETs) through cypepoxygenases share many function including 
vasodilation, anti-inflammation and anti-thrombosis, which further validate their close 
relationship. This interaction between A2AAR and EETs are shown to contribute to 
exaggerated vascular response to adenosine in HS treated rat PGMV (58) and mouse aorta 
(71-72). Therefore, PGMV vasodilation elicited by EETs synthesis through A2AAR activation 
in response to HS diet is suggested to represent adaptive vascular mechanism to regulate GFR 
and salt and water excretion. Similar findings in aorta imply that this adaptive vasodilatory 
response is not limited to renal vasculature and thus, could be a systemic phenomenon to 
mediate anti-pressor effects. Few studies have provided an important insight into the possible 
role of A2AAR-EETs pathway in the pathogenesis of salt-sensitive hypertension (SSH) in rats. 
Liclican et al. (57) demonstrated that when placed on seven days HS diet, Dahl salt-resistant 
rats showed greater vasodilation with upregulation of A2AAR and cyp-epoxygenases enzyme 
whereas Dahl salt-sensitive rats did not. This observation suggests that inability to upregulate 
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A2AAR-EETs in response to salt loading could lead to salt-induced hypertension. There is, 
however, no direct evidence regarding the potential outcomes of HS diet on vascular tone, 
signaling mechanism and BP regulation in the absence of A2AAR. Therefore, direct evaluation 
of the role of A2AAR signaling on long-term HS diet treatment is required using A2AAR 
deficient mice. 
EETs and soluble epoxide hydrolase: 
Four different regio-isomers of EETs include 5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EETs. 
Half-life of EETs in vivo has been estimated to be few seconds to minutes (21) as their 
intracellular levels are tightly regulated. It is well documented that EETs can be inactivated or 
metabolized by number of ways such as ω-oxidation, β-oxidation, chain elongation, 
esterification, conjugation, and hydration by sEH, among which the latter appears to play a 
prominent role in the metabolism of EETs. sEH is widely distributed in mammalian tissue 
such as liver, kidney, intestine, and vascular tissue. There are two well-studied epoxide 
hydrolase enzymes that differ by subcellular localization and substrate selectivity: microsomal 
epoxide hydrolase (mEH) and sEH. mEH present in microsomes metabolize carcinogenic or 
genotoxic epoxide contributing in detoxification of drugs. sEH predominantly located in 
cytosol is also present in the peroxisome (46, 70). sEH is a homodimer and each subunit 
contains carboxyl and amino-terminal domains. The active site of epoxide hydrolysis is 
located in the carboxyl-terminal domain and amino-terminal domain of sEH contains 
phosphatase activity (3). The c-terminal domain catalyzes the addition of water to an epoxide 
to yield a vicinal diol. Fig 1.5 represents the structure of sEH (Hammock lab). 
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sEH suppresses the beneficial cardiovascular effects of EETs including vasodilation, anti-
migratory actions on vascular smooth muscle cells, and anti-inflammatory actions. 
Furthermore, sEH is implicated in different models of hypertension including angiotensin II, 
spontaneously hypertensive rats (SHR) and Dahl salt-sensitive rats and also in various other 
cardiovascular diseases. Thus, inhibiting this enzyme would be expected to enhance beneficial 
cardiovascular properties of EETs. sEH inhibitors are being rapidly developed for use in 
research. First landmark study in 2000 showed that treatment with sEH inhibitor increased 
EETs level and lowered BP in SHR (113). BP was lowered in angiotensin II-induced 
hypertension by chronic sEH inhibitors (50). Oral administration of sEH inhibitors also 
showed anti-hypertensive and end-organ-protective effects (47).  Furthermore, sEH inhibitor 
is also shown to prevent early salt-sensitive hypertension (55). Other investigations have 
displayed cardio-protective effects from ischemic events (89) and anti-inflammatory effects 
(115) using sEH inhibitors and sEH null mice. Hence, number of studies has provided 
exciting findings on the broad potential for sEH inhibitors as cardiovascular therapeutic 
agents. In addition, genetically-manipulated mice offer as an important tool to further 
elucidate the role of sEH. sEH gene deletion attenuated renal injury and inflammation with 
deoxycorticosterone acetate (DOCA)-salt hypertension (66).  
Our lab has previously reported downregulation of sEH with HS diet in mouse aorta. 
Nonetheless, the interaction between sEH and HS diet in A2AAR deficient mice has not been 
explored. Since increased sEH activity is implicated in hypertensive animal model and 
vasoconstriction (50), it is essential to evaluate the role of sEH in relation to A2AAR 
deficiency-mediated change in vascular reactivity in HS fed mice. Also, investigating the 
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relation between sEH and A2AAR is important to understand the interaction between EETs 
formation and degradation pathway. Hence, this dissertation addresses these issues. 
 
Role of PPARγ and vascular tone regulation: 
The peroxisome proliferator-activated receptors (PPARs) are ligand activated transcriptional 
factors belonging to the family of three isoform (α, β/δ, γ) nuclear receptors that are activated 
by lipid metabolites and play a critical role in glucose homeostasis and lipid metabolism. 
PPARs have the ability to bind to large number of ligands mainly because of their large 
ligand-binding domain (74, 110). PPARs are involved in many functions such as regulation of 
vascular tone, inflammation and energy homeostasis. Accumulating evidence suggests that 
PPARγ contributes in regulation of vascular function and blood pressure in addition to its 
well-recognized role in adipogenesis and insulin sensitivity. Thiazolidinedione, specific 
PPARγ ligands, have been reported to lower blood pressure and provide cardiovascular 
benefits through regulating vascular function and vascular tone (84). Activation of PPARγ 
enhances nitric oxide (NO) production (78), whereas disruption of PPARγ in endothelial cells 
reduces NO release (51). Vascular tone is also affected by PPARγ through suppression of 
endothelin-1 (ET-1) synthesis in endothelial cells (27). Moreover, PPARγ activation promotes 
anti-inflammatory and antioxidant effects by decreasing NADPH oxidase subunits levels and 
increasing copper/zinc superoxide dismutase expression and activity (48). In smooth muscle 
cells, PPARγ activation inhibit the L-type Ca2+ current (11), thereby reducing vascular 
contraction. TZDs may promote vascular relaxation through stimulation of KCa channel; 
however, the mechanism remains unclear (33). In addition, pioglitazone is shown to promote 
activation of myosin light chain phosphatase (4) and also inhibition of Rho kinase activity in 
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vasculature (104). Therefore, PPARγ is involved in regulation of vascular tone through 
modulating vasodilation and vasoconstriction pathways. 
 
Role of EETs and PPARγ in the regulation of vascular reactivity:  
EETs receptors have not been identified and cloned yet and the mechanism by which EETs 
mediate their effects is largely unknown. However, mounting evidence suggest that EETs act 
through receptors and some studies suggest that EETs have affinity to already known binding 
sites and receptors (92) . Report showing that EETs specifically binds to the plasma 
membrane of human U937 transformed monocytes (108) indicates the presence of EETs 
receptor.   Some functional effects of EETs occur through activation of either the guanine 
nucleotide binding protein Gαs (29, 111) or the Src signal transduction pathways (100), 
suggesting that EETs act by binding to membrane receptors. EETs seem to activate vascular 
smooth muscle cells KCa channel through G-protein dependent mechanism in which the 
cAMP and PKA are involved (16, 95). While other evidence indicates that the modulation of 
gene expression occurs through an intracellular action of EETs. As EETs produce wide 
variety of biochemical and functional responses, it is doubtful that a single mechanism or 
signal transduction pathway can account for all of their actions (16). 
Many of the longer-term actions of the cyp-epoxygenases pathways are common to PPARs 
activation. Activation of PPARs, similar to the effect of EETs, causes regulation of vascular 
tone and inhibition of vascular cell proliferation, migration and inflammation. Proposed 
endogenous PPAR ligands have originated from AA and linoleic acid metabolism, among 
which possible ligands could be produced by cyp-epoxygenases pathway. Few studies have 
been conducted to examine the possible candidacy of epoxygenases metabolites as PPAR 
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ligands. Cyp4a-metabolite of EETs has been reported to be high affinity PPAR ligands (24, 
34). Moreover, shear stress-induced EETs generation by endothelial cells is shown to have 
paracrine anti-inflammatory effect through inhibition of NFkB by activating PPARγ (60), 
implying that EETs is the effector of PPARγ. Also, EETs protects against angiotensin II-
induced abdominal aneurysm in cyp2j2-overexpressed mice through PPARγ (14). In addition, 
EETs-induced angiogenesis in endothelial progenitor cells in patients with acute myocardial 
infarction is demonstrated to be dependent on PPARγ (109). The EETs-PPARγ pathway may 
therefore represent a novel endogenous pathway by which transitory lipid mediators control 
vascular cell function. Henceforth, this dissertation evaluates the role of PPARγ on A2AAR-
EETs mediated regulation of vascular tone in HS and NS fed mice. 
 
Role of Adenosine A2A receptors and PPAR γ in the regulation of vascular tone: 
Although adenosine and PPARγ has many common functions, their interaction has not been 
studied well. Positive association has been revealed by He et al., (44), in which they have 
shown the link between A2AAR and PPARγ. Also, they have demonstrated increase in 
expression and activation of PPARs with A2AAR activation. Connection between A2AAR and 
PPARγ is poorly understood. This project utilizes A2AAR wild-type and A2AAR-null mice on 
a HS and NS diet to further investigate their relationship in the regulation of vascular tone.  
Role KATP channels in the regulation of vascular tone: 
KATP channels are present in vascular smooth muscle cells and play an important role in the 
vascular tone regulation. Fig 1.6 shows the structure of KATP channels (35). KATP channel is 
composed of four inwardly rectifying K+ channel subunits (KIR6.1 or KIR6.2); each KIR 
subunit is associated with a larger regulatory sulphonylurea receptors (SUR) (5). Multiple 
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isoforms of the SUR exists (SUR1, SUR2A, and SUR2B). KATP channel, as its name suggest, 
is sensitive to ATP concentration, where intracellular ATP promotes closure and high ADP 
favors opening of KATP channel. The inhibitory effects of ATP result from binding of ATP to 
the KIR subunit whereas channel activation by Mg2+-dinucleotide occurs via interaction with 
SUR (5). Opening of KATP channels lead to outward flow of K+ current down the 
concentration gradient and hyperpolarization of cells. The associated membrane 
hyperpolarization closes voltage-dependent Ca2+ channels, resulting in reduction of 
intracellular Ca2+ leading to vasodilation. They are activated under physiological as well as 
pathophysiological conditions such as hypoxia, ischemia, septic shock and disease states, 
playing an important role in regulation of vascular tone and tissue perfusion. KATP channel not 
only responds to changes in intracellular metabolism but also is activated by a variety of 
endogenous vasodilators such as prostanoids, calcitonin gene-related peptide, β-adrenoceptor 
agonists and adenosine (7, 25). Contraction to endogenous vasoconstrictor occurs due to 
inhibition of KATP channels. 
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Figure 1.6: The structural basis for KATP channel activity (Flagg et al., 2010) 
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Role of Adenosine and KATP channels in the regulation of vascular tone: 
It is well established that adenosine cause vasodilation in various vascular beds. Adenosine is 
known to elicit its vasodilatory effects through acting on adenosine A2AAR and A2BAR. 
Number of signaling pathways has been attributed to vascular relaxation mediated by A2AAR, 
which involves direct interaction with ion channels. Several studies have shown the 
contribution of KCa channel in vascular relaxation (13, 20). Other studies have demonstrated 
adenosine-mediated hyperpolarization of arteries by opening of KATP channels.  Mounting 
evidence support the role of KATP channels in adenosine-mediated vasodilation. Adenosine 
evokes retinal vasodilation by activating A2AAR and subsequently producing NO and opening 
of KATP channels (45). In coronary arteries, A2AAR stimulation is shown to increase coronary 
flow alteration through KATP channels (26, 86). In addition, A2AA coupling with KATP 
channels has been reported in renal arteries to elicit vasodilation (82, 98). Studies from our lab 
and others suggest that A2AAR-mediated activation of KATP channels occurs through EETs (20, 
72). Also, EETs acts as a potent KATP channels activator (61, 112). This dissertation aims to 
investigate the contribution of KATP channels on vascular tone regulation wild-type and 
A2AAR-deficient mice on a HS diet. 
 
Role of PPAR γ and KATP channels in vascular reactivity: 
Emerging evidence has shown the role of PPARγ in regulation of vascular tone and 
particularly, in vasodilation. Many studies suggest that PPARγ activation regulates gene 
expression of vasodilators in order to mediate its effect on vascular tone. Nonetheless, 
spontaneous change in vascular reactivity induced by PPARγ is speculated to happen through 
non-transcriptional pathway, as rapid modulation of vascular tone is a fast process. Reports 
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suggest that PPARγ elicits relaxation in pulmonary arteries by activating KATP channel 
through unknown mechanism (52). Another intriguing finding by Atkins et al. (4) displayed a 
PPARγ-dependent decrease in phosphorylation of myosin light chain phosphatase (MLPT1) 
thereby, activating MLPT1 which results in vasodilation. Only very few studies have 
indicated the non-transcriptional effects of PPARγ, thus, further investigations are necessary 
to delineate the relationship between PPARγ and KATP channels. In this study, we examine the 
role of PPARγ and KATP channels in modulation of vascular tone in response to HS diet in the 
presence and absence of A2AAR. 
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Project Summary: 
HS diet is widely associated with increase in BP and also is known to elicit other 
cardiovascular disorders. Abnormal vascular reactivity is not only an important predictor of 
high BP but also key determinant of vascular and cardiac diseases regardless of BP alteration. 
Exposure to HS diet has been linked to modulation of adenosine-mediated vascular reactivity 
through vasodilators involving A2AAR and EETs. These pathways may represent adaptive 
mechanism contributing in inhibiting impairment of vascular function in response to HS diet.  
However, no direct evidence is available showing the importance of A2AAR signaling 
pathway as a compensatory process to HS diet. Therefore, direct evaluation of the role of 
A2AAR on HS diet fed mice is required to show a direct link between lack of A2AAR and 
vascular reactivity dysfunction. Thus, understanding the signaling mechanism contributing to 
HS-induced modulation of vascular tone in the presence and absence of A2AAR will enable us 
to determine the key signaling mediators involved in vascular abnormality in response to HS 
diet and allow us to develop better therapeutic targets. Hence, the purpose of this dissertation 
is to determine the effect of HS diet (4 weeks) on adenosine-mediated vascular response and 
underlying signaling mechanism using A2AAR-/- and A2AAR+/+ mice on a HS and NS diet. 
 
Specific Aim 1: Determine the role of A2AAR in HS-induced changes in vascular 
reactivity and its signaling mechanism using A2AAR+/+ and A2AAR-/- mice. 
Sub-specific aim 1A:  Examine the effect of HS diet (4 weeks) on vascular reactivity to 
adenosine and its mechanism involving EETs using A2AAR+/+ and A2AAR-/- mice. 
Sub-specific aim 1B: Investigate the contribution of A1AR and cyp4a in HS-induced vascular 
contraction in the absence of A2AAR. 
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Specific Aim 2: Delineate the signaling mechanism involved in adenosine-induced 
regulation of vascular tone downstream of A2AAR and EETs in HS-fed A2AAR+/+ and 
A2AAR-/- mice. 
Sub-specific aim 2A:  Examine the role of PPARγ and KATP channels in A2AAR-EETs-
mediated vascular reactivity in A2AAR+/+ and A2AAR-/- mice on a HS diet. 
Sub-specific aim 2B: Investigate the contribution of sEH in adenosine-mediated vascular 
reactivity in A2AAR+/+ and A2AAR-/- mice on a HS diet. 
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CHAPTER TWO: 
HIGH SALT DIET EXACERBATES VASCULAR CONTRACTION IN THE 
ABSENCE OF A2A RECEPTOR  
Journal of Cardiovascular Pharmacology, May 2014 
(Used with permission from J. Cardiovasc Pharmacol) 
 
Abstract: 
High salt (4%NaCl, HS) diet modulates adenosine-induced vascular response through 
adenosine A2A-receptor (A2AAR). Evidence suggests A2AAR stimulates cyp450-epoxygenases, 
leading to epoxyeicosatrienoic acids (EETs) generation. The aim of this study was to 
understand the vascular reactivity to HS and underlying signaling mechanism in the presence 
or absence of A2AAR. Therefore, we hypothesized that HS enhances adenosine-induced 
relaxation through EETs in A2AAR+/+, but exaggerates contraction in A2AAR-/-. Organ-bath 
and Western-blot experiments were conducted in HS and normal salt (NS, 0.18% NaCl)-fed 
A2AAR+/+ and A2AAR-/- mice aortae. HS produced concentration-dependent relaxation to non-
selective adenosine analog, NECA in A2AAR+/+, whereas contraction was observed in A2AAR-
/-
 mice and this was attenuated by A1AR antagonist (DPCPX).  CGS-21680 (selective A2AAR-
agonist) enhanced relaxation in HS-A2AAR+/+ vs. NS-A2AAR+/+, that was blocked by EETs 
antagonist (14,15-EEZE). Compared to NS, HS significantly upregulated expression of 
vasodilators A2AAR and cyp2c29, while vasoconstrictors A1AR and cyp4a in A2AAR+/+ were 
downregulated.  In A2AAR-/- mice, however, HS significantly downregulated the expression of 
cyp2c29, while A1AR and cyp4a were upregulated compared to A2AAR+/+ mice. Hence, our 
data suggest that in A2AAR+/+, HS enhances A2AAR-induced relaxation through increased cyp-
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epoxygenases-derived EETs and decreased A1AR levels, whereas in A2AAR-/-, HS 
exaggerates contraction through decreased cyp-epoxygenases and increased A1AR levels. 
Introduction: 
Adenosine, a breakdown product of ATP, acts as a local modulator with generally 
cytoprotective function in response to stressful conditions such as ischemia, hypoxia, injury, 
and inflammation (23, 26). Besides many physiological effects elicited by extracellular 
adenosine such as inhibition of renin release, platelet aggregation, inflammation, lipolysis and 
sympathetic neurotransmission (34), its effect on vasculature  is crucial for vasoregulation 
(14) and physiological control of mean arterial pressure (MAP), (1, 19).  Adenosine mediates 
its effects via four adenosine receptors: A1, A2A, A2B, and A3 (10). Activation of A2AAR and 
A2BAR are known to mediate vasodilation in different vessels (6, 8, 16, 28-29, 32), whereas 
A1AR and A3AR are believed to be involved in vasoconstriction (12, 14). Adenosine receptors 
especially A1AR and A2AAR are also involved in the regulation of blood pressure (BP). 
A2AAR causes renal vasodilation (13) and attenuates tubuloglomerular feedback (5). A2AAR 
knockout mice as well as rats treated with selective A2AAR antagonist displayed an elevated 
BP (27), (19). A1AR is involved in water and salt retention (24), mediating tubuloglomerular 
feedback response (35), constriction of afferent arterioles (38), lowering of heart rate and 
suppression of renin release (2).  
Growing evidence suggests a link between high dietary salt intake and activation of adenosine 
receptors and A2A receptor in particular (22, 29-30). Data demonstrating upregulation of 
A2AAR expression in response to salt loading (21, 29), accompanied by enhanced A2AAR 
mediated vasodilation (6, 21-22, 29-30) further support the role of adenosine A2AAR during 
high salt (HS) diet.  Stimulation of A2AAR is reported to result in an eNOS-independent 
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vasodilation (30) and reduction in MAP (1). A1AR, responsible for vasoconstriction, is shown 
to be downregulated in HS treated animals (21, 29). In addition, elevated levels of adenosine 
generation have been detected upon the exposure to HS diet in rats (33, 39). 
Apart from adenosine, another important vasoregulatory factor associated with HS diet is cyp-
epoxygenase enzyme that belongs to cytochrome P450s (cyp450) family (9, 15). Two major 
subtypes of cyp450 enzymes include cyp-epoxygenases and ω-hydroxylases that play an 
important role in regulating vascular tone (9, 15, 18). It is well documented that cyp- 
epoxygenases catalyze the metabolism of arachidonic acid (AA) into epoxyeicosatrienoic 
acids (EETs), a potent vasodilator and natriuretic agent (3), whereas, ω-hydroxylase 
metabolizes AA to 20-hydroxyeicosatetraenoic acid (20-HETE), a potent vasoconstrictor (11, 
28-29) and natriuretic. HS diet is associated with increase in renal cyp-expoxygenases activity 
as a protective mechanism against rise in BP (4, 20-21). Inhibition of cyp-epoxygenases 
activity with clotrimazole is shown to contribute to the surge in MAP and development of salt 
sensitivity in rats fed HS diet, whereas salt itself was unable to increase blood pressure (25). 
Unlike EETs, the production of 20-HETE is found to be lower in glomeruli isolated from 
kidneys of rats fed HS diet than in kidneys of rats fed low salt diet (17). Increased levels of 
20-HETE are shown to promote vasoconstriction that contributes to the progression of 
hypertension (11, 37).  
Emerging evidence indicates a close relationship between HS-induced activation of A2AAR 
and EETs generation through enhanced cyp-epoxygenases activity (7, 30-31). In previous 
study, we found that non-selective adenosine analog (NECA) and selective adenosine A2A 
receptor agonist (CGS-21680) showed enhanced dilation in aortae from mice fed HS 
compared to mice fed low salt diet and the enhanced dilation in HS diet fed mice was blunted 
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by cyp-epoxygenases inhibitor, methylsulfonyl-propargyloxyphenylhexanamide (MSPPOH) 
(29).  Moreover, Liclican et al., (21) reported that inability to upregulate the adenosine 
A2AAR–EETs pathway in response to salt loading confers salt sensitive hypertension in rats.  
Although there is some indication as to the possible adaptive role of A2AAR receptor and cyp- 
epoxygenases mediated vasodilation during HS diet, studies evaluating the ramifications of 
HS diet in terms of vascular response and biochemical signaling resulting from the A2AAR 
gene deletion are lacking. On the basis of these prior investigations, it is important to examine 
the effects of HS diet on vascular reactivity in the absence of A2AAR in order to directly 
evaluate the role of A2AAR and more importantly to understand the underlying mechanism 
involved in vascular pathophysiological changes. Therefore, using HS and NS fed A2AAR+/+ 
and A2AAR-/- mice, we aim to determine the role of A2AAR on vascular response and its 
downstream mechanism. 
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MATERIALS AND METHODS 
The experimental and animal care protocols used in this study were approved by the West 
Virginia University Institutional Animal Care and Use Committee and carried out according 
to the principles and guidelines of the Institute of Laboratory Animal Resources Guide for the 
Care and Use of Laboratory Animals. Ten-weeks-old inbred male and female CD-1 (A2AAR-/- 
and A2A AR+/+ mice) obtained from Dr. Ledent (Belgium), bred and maintained in our facility 
at West Virginia University were placed on a whole-grain diet containing either 0.18% NaCl, 
normal salt (NS) or 4% NaCl, high salt (HS) (TD88311 and TD92100 diets; Teklad, Madison, 
WI). The initial characterization of A2AAR+/+ and A2AAR-/- mice has been previously 
described by Ledent et al. (19).  In brief, to produce mice on a homogenous genetic 
background, first-generation heterozygotes were bred for 14 generations to mice on a CD-1 
(Charles River Laboratories) outbred background, with selection for the mutant A2AAR gene 
at each generation by PCR. Fourteenth generation heterozygotes were bred together to 
generate A2AAR+/+ and A2AAR-/- (1:1, their mate controls) mice (19).  All mice were studied 4-
5 weeks after assignment to either the NS or HS group. 
Isometric tension Muscle bath experiments: 
HS and NS fed A2AAR+/+ and A2AAR-/- mice were euthanized with pentobarbital sodium (100 
mg/kg, i.p.). The aorta was gently removed after thoracotomy, cleaned of fat and connective 
tissues, and cut transversely into rings of 3-4 mm in length as described previously by us (28-
29). Extreme care was taken not to damage the endothelium. The rings were mounted 
vertically between two stainless steel wire hooks. The two rings were suspended in 10 ml 
organ baths containing modified Krebs-Henseleit buffer (in 118 mM of NaCl, 4.8 mM of KCl, 
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1.2 mM of MgSO4, 1.2 mM of KH2PO4, 25 mM of NaHCO3, 11 mM of glucose, and 2.5 mM 
of CaCl2). The buffer was maintained around pH 7.4 at 37◦C. The aortic rings were 
equilibrated for 60 min with a resting force of 1 g as described previously by us (28-29). At 
the end of the equilibration period, tissues were contracted with KCl (50 mM) to check the 
viability. Aortic rings were then constricted with phenylephrine (PE, 10-6 M) and changes in 
tension were monitored continuously with a fixed range precision force transducer (TSD, 125 
C, BIOPAC system). Data were recorded using MP100 WSW, BIOPAC digital acquisition 
system and analyzed using Acknowledge 3.5.7 software (BIOPAC system). The vascular 
endothelium was tested to determine whether it was intact, as previously described by our 
laboratory (28-29) through acetylcholine (ACh, 10-6 M) on pre-contracted aortic rings with 
phenylephrine (PE). Preparations were then washed several times with Krebs-Henseleit buffer 
solution and allowed to equilibrate for 30 min before the experimental protocol began. For all 
tests, the contraction and relaxation responses are expressed as % decrease or % increase of 
PE-induced pre-contraction. 
Adenosine agonist-induced vascular response in A2AAR+/+ and A2AAR-/- mice fed HS and 
NS diet:                                                                                                                                    
The responsiveness of pre-contracted aortic rings from A2AAR+/+ and A2AAR-/- mice fed HS 
and NS diet to non-selective adenosine analog, 5’-N-ethylcarboxamidoadenosine (NECA), the 
selective A2A receptor agonist, 2-p-(2-carboxyethyl) phenethylamino-5′-N-ethylcarboxamido 
adenosine hydrochloride (CGS 21680), or selective A1 receptor agonist, 2-chloro-N(6)-
cyclopentyladenosine (CCPA) were obtained by cumulative addition of these drugs to the 
organ bath in 1-log increments to obtain a concentration-response curve (CRC) as previously 
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described (28-29). All concentration response determinations were run in parallel on pairs of 
rings from either HS (A2AAR+/+ and A2AAR-/-) or NS (A2AAR+/+ and A2AAR-/-). 
Effects of A1AR and A2AAR antagonists, and cyp4a inhibitor on NECA and 20-HETE-
induced vascular response in A2AAR+/+ and A2AAR-/- mice fed HS and NS diet: 
Selective A1AR antagonist, 8-cyclopentyl-1,3-dipropylxanthine  (DPCPX; 10 µM) or 
selective A2AAR antagonist (SCH 58261; 10 µM) or selective cyp4a inhibitor, dibromo-
dodecenyl-methylsulfimide (DDMS; 10 µM) was added 30 min before contraction of the 
tissue with PE and was present throughout the experiment. These experiments were performed 
in parallel on four rings from the same aorta with two serving as control and two treated with 
either DPCPX or SCH 58261 or DDMS respectively. 
Effects of EETs antagonist on CGS 21680-induced vascular response in A2AAR+/+ and 
A2AAR-/- mice fed HS and NS: 
Selective EET antagonist, 14,15-epoxyeicosa-5(z)-enoic acid (14,15-EEZE;10 µM) was added 
30 min before contraction of the tissue with PE, and was present throughout the experiment. 
These experiments were performed in parallel on four rings from the same aorta with two 
serving as control and two treated 14,15-EEZE. 
Western-blot analysis:  
Aortae from HS and NS fed A2AAR+/+ and A2AAR-/- mice were isolated and each sample was 
homogenized with 130 µL RIPA buffer (Cell Signaling Technology Inc) on wet ice. The 
samples were transferred to dry ice for 5 min and then thawed on wet ice. After thawing, 
lysates were sonicated and the samples were vortexed and centrifuged for 5 min at 12,000 rpm 
at 4°C. Then, the supernatant was stored at –80°C. Protein was measured using Bio-Rad assay 
based on the Bradford dye procedure with bovine serum albumin (BSA) as a standard. The 
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protein mixture was divided into aliquots and stored at –80°C. At the time of analysis, samples 
were thawed and 30 µg of total protein per lane was loaded on a slab gel. Proteins were 
separated by SDS-PAGE using 10% acrylamide gels (1-mm thick). After electrophoresis, the 
proteins on the gel were transferred to nitrocellulose membrane (Hybond-ECL) by 
electroelution. Protein transfer was confirmed by employing pre-stained molecular weight 
markers (Bio-Rad Laboratories, Hercules, CA). Following blocking with either 5% nonfat dry 
milk or BSA, the nitrocellulose membranes were incubated with primary antibodies for 
cyp2c29 (Dr. Zeldin, NIEHS /NIH), cyp4a (Santa Cruz Biotecnology, Santa Cruz, CA), A1AR 
(Sigma Chemicals) and A2AAR (Alpha Diagnostics). 1:1000 primary antibody concentration 
was used for all antibodies. β-actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was 
used as an internal control to normalize the target protein expression in each lane. The 
secondary antibody was a horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG. 
The membranes were developed using enhanced chemiluminescence (Amersham 
BioSciences) and exposed to X-ray film for the appropriate time. The data are presented as the 
ratio of target protein expression to β-actin.  
 
Chemicals, drugs & antibodies: Phenylephrine hydrochloride and acetylcholine chloride 
were dissolved in distilled water. NECA, CGS 21680, SCH-58261, CCPA, DPCPX, 
indomethacin, and L-NAME (Sigma Chemicals, St. Louis, MO) were dissolved in 100% 
DMSO as 10 mM stock solutions, which were followed by serial dilutions in distilled water. 
14,15-EEZE, DDMS and 20-HETE (Dr. Falck) were dissolved in 100% ethanol. Cyp2c9 
antibody (Dr. Zeldin, NIEHS /NIH), cyp4a antibody (Santa Cruz Biotechnology), A1AR 
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(Sigma Chemicals, St. Louis, MO) and A2AAR (Alpha Diagnostics) were used for Western-
blot experiments. 
 
Statistical Analysis: Statistical data are reported as mean ± SEM. One-way analysis of 
variance (ANOVA) was used to compare difference among groups, and two ways ANOVA 
for repeated measure, followed by Tukey post hoc test to compare the vascular responses to 
antagonist SCH, DPCPX, 14,15-EEZE, DDMS. Differences were considered significant if 
p<0.05. Further, densitometry of Western-blot analysis (cyp4a, cyp2c29, A1AR and A2AAR) 
data was expressed as mean ± SEM in arbitrary units. All the statistical analyses were 
performed using Graph Pad Prism statistical package. 
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RESULTS: 
Effects of SCH 58261 on NECA-dependent vascular response in HS and NS diet fed 
A2AAR+/+ and A2AAR-/- mice:  
NECA produced enhanced vascular relaxation in HS-fed A2AAR+/+ mice compared to 
NS- fed A2AAR+/+ mice (p<0.05; Fig. 2.1a). HS–induced vascular response to NECA was 
significantly different in A2AAR+/+ vs. A2AAR-/- mice (p<0.05; Fig. 2.1a). HS diet induced 
higher relaxation (+17.34 ± 2.50%) to NECA (10-6 M) in A2AAR+/+ mice whereas, HS diet 
caused contraction (-56.77 ± 3.49%) in A2AAR-/- mice (P<0.05; Fig. 2.1a). Interestingly no 
significant difference was observed between aortic responses in HS-fed A2AAR-/- mice and 
NS-fed A2AAR-/- mice (p>0.05; Fig. 2.1a). To pharmacologically confirm if HS-mediated 
relaxation is dependent on A2AAR, we used selective A2A receptor antagonist, SCH 58261 for 
NECA CRC (Fig. 2.1b).  SCH 58261 (1 µM) blocked NECA (10-6 M) dependent relaxation 
response (+17.34 ± 2.50%) in HS-fed A2AAR+/+ aortae into contraction (-12.20 ± 3.62%, 
p>0.05; Fig. 2.1b).  
Effects of L-NAME, indomethacin and 14,15-EEZE on CGS 21680-dependent vascular 
response in HS and NS diet fed A2AAR+/+ and A2AAR-/- mice: 
Selective A2AAR agonist, CGS 21680 demonstrated concentration-dependent 
relaxation in both HS and NS-fed A2AAR+/+ mice with a significant difference (p<0.05; Fig 
2.2a), but no significant difference was noted between HS and NS diet fed A2AAR-/- mice 
(p>0.05; Fig. 2.2a). CGS 21680 (10-6M) produced significantly greater relaxation (+21.4 ± 
1.34%) in HS-fed A2AAR+/+ mice than in NS-fed A2AAR+/+ mice (+12.96 ± 1.52; p<0.05; Fig 
2.2a) suggesting an increased A2AAR activity with HS diet. 
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Relaxation response to CGS 21680 in both HS and NS-fed A2AAR+/+ mice was neither 
affected by cycloxygenase inhibitor, indomethacin (1 µM) (p>0.05) nor by e-NOS inhibitor, 
L-NAME (100 µM) (p>0.05; not shown). However, EETs antagonist, 14,15-EEZE (10 µM), 
completely abolished CGS 21680-dependent relaxation (from +21.4 ± 1.34% to contraction -
1.08 ± 2.95 % at 10-6 M; p<0.05) in HS-fed A2AAR+/+ mice (Fig. 2.2b). Relaxation to CGS 
21680 (10-6 M) in NS-fed A2AAR+/+ mice was also significantly blocked by 14,15-EEZE (10 
µM) but to a lower extent compared to HS-fed A2AAR+/+ mice (p<0.05; Fig. 2.2b). These data 
suggest that A2AAR mediated relaxation in HS–fed A2AAR+/+ mice is independent of NO and 
cycloxygenase but dependent on EETs.  
Effects of DDMS on NECA-dependent response in HS and NS diet fed A2AAR+/+ and 
A2AAR-/- mice: 
           In Fig. 2.3, contraction to NECA (10-6 M) in NS-fed A2AAR+/+ mice was blocked by 
cyp4a inhibitor DDMS (10 µM), and the response changed from a contraction of -14.42 ± 
7.74% to  a relaxation of +10.0 ± 3.83% (p<0.05; Fig. 2.3a). Also, in NS-fed A2AAR-/- mice, 
DDMS (10 µM) attenuated NECA-induced contraction (from -48.27 ± 2.83% to -22.1 ± 
4.37% at 10-6 M; p<0.05; Fig. 2.3b), suggesting the role of 20-HETE, an arachidonic acid 
metabolite of cyp4a, in NECA-dependent contraction. Interestingly, NECA-induced 
contraction in HS-fed A2AAR-/- mice was no different with 10 µM DDMS treatment (without 
treatment: 57.59 ± 2.84% vs. DDMS treated: 47.03 ± 4.38% at 10-6 M; p>0.05; Fig. 2.3b). 
This indicates that 20-HETE does contribute to the contraction in NS-fed A2AAR+/+ and 
A2AAR-/- mice but not in HS-fed A2AAR-/- mice. 
Effects of DPCPX on NECA-induced vascular response in HS and NS diet fed A2AAR+/+ 
and A2AAR-/- mice: 
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Since A1 adenosine receptor is also involved in vasoconstriction (12), we investigated the role 
of A1AR in NECA-induced contraction in NS-A2AAR+/+ mice (Fig. 2.4a). Selective A1 
antagonist, DPCPX (10 µM) blocked NECA (10-6 M)-dependent contraction (from -14.42 ± 
7.74% to relaxation +14.96 ± 3.75%; p<0.05; Fig. 2.4a) in NS-fed A2AAR+/+ mice. But, 
DPCPX did not have any significant effect on DPCPX treated HS-fed A2AAR+/+ mice 
compared to non-treated HS-fed A2AAR+/+ mice (p>0.05; Fig. 2.4a). Further, DPCPX reversed 
NECA (10-6 M)-mediated contraction from 51.1 ± 3.01% to +1.02 ± 3.18% in NS-fed A2AAR-
/- (p<0.05; Fig. 2.4b) and 57.29 ± 2.84% to 1.32 ± 5.47% in HS-fed A2AAR-/- (p<0.05; Fig. 
2.4b).  No difference was found between 10 µM DPCPX and 0.1 µM DPCPX (data not 
shown). 
CCPA-dependent vascular response in HS and NS diet fed A2AAR+/+ and A2AAR-/- mice: 
Selective A1 agonist, CCPA yielded higher contraction in A2AAR-/- mice compared to 
A2AAR+/+ mice regardless of salt content in the diet (Fig. 2.4c). NS-fed A2AAR-/- and HS-fed 
A2AAR-/- mice showed robust vascular contraction (77.73 ± 4.26% and 52.08 ± 4.29%) to 
CCPA (10-6 M) compared to their controls NS-fed A2AAR+/+ and HS-fed A2AAR+/+ (43.05 ± 
7.51% and 29.31 ± 4.81%; p<0.05; Fig. 2.4c), respectively. Interestingly, CCPA (10-6 M) 
produced significantly lower contraction in HS-fed A2AAR-/- mice (52.08 ± 4.29%) compared 
to NS-fed A2AAR-/- mice (77.73 ± 4.26%; p<0.05; Fig. 2.4c). 
Effects of DPCPX on 20-HETE-dependent vascular response in HS and NS diet fed 
A2AAR+/+ and A2AAR-/- mice: 
            We investigated the role of A1AR in 20-HETE-induced contraction in NS/HS-fed 
A2AAR+/+ and A2AAR-/- mice (Fig. 2.5a, b). Selective A1 antagonist, DPCPX was unable to 
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block 20-HETE (10-6 M)-induced contraction (Fig. 2.5a, b) in NS/HS-fed A2AAR+/+ and 
A2AAR-/- mice, suggesting that 20-HETE is downstream of A1AR.  
A2AAR, cyp2c29, cyp4a and A1AR expression in HS and NS-fed A2AAR+/+ and A2AAR-/- 
mice: 
The expression of A2AAR (~45 kDa) protein was upregulated by ~30% in HS-fed 
A2AAR+/+ mouse aortae (129.7 ± 1.63%) compared with the control NS-fed A2AAR+/+ mouse 
aortae (100.1 ± 2.16%, p<0.05; Fig. 2.6).  
Also, cyp2c29 (~55 kDa) protein showed increased expression by ~64 % in HS-fed 
A2AAR+/+ mouse aortae (164.2 ± 18.50%) compared to the control NS-fed A2AAR+/+ mouse 
aorta (100 ± 5.55%; p<0.05, Fig. 2.7).  Significantly diminished level of cyp2c29 (~54%) was 
observed in HS-fed A2AAR-/- mice (59.8 ± 5.20%; Fig. 2.7) compared to HS-fed A2AAR+/+ 
mice (164.2 ± 18.50%; p<0.05; Fig. 7).  
  Substantial elevation in the level of cyp4a (~58 kDa; ~74 %) protein was found in NS-
fed A2AAR-/- mice (173.8 ± 12.90%) compared to NS-fed A2AAR+/+ (100.9 ± 1.34%; p<0.05, 
Fig. 2.8). On the contrary, cyp4a expression was decreased by ~46 % in HS-fed A2AAR+/+ 
mice (54.1 ± 7.88%; p<0.05; Fig. 2.8) compared to the NS-fed A2AAR+/+ mouse aortae (100.9 
± 1.34%). Cyp4a level was ~50% higher in HS-fed A2AAR-/- mouse aortae (103.9 ± 6.53%; 
p<0.05) compared to HS-fed A2AAR+/+ mice (54.1 ± 7.88%; Fig. 2.8). 
  A1AR (~37 kDa) protein expression observed in both NS-fed A2AAR-/- and HS-fed 
A2AAR-/- mice (151.60 ± 26.85% and 120.1 ± 11.94%) was ~51.6% and ~45% higher 
compared to their control counterparts NS and HS-fed A2AAR+/+ mouse aortae (100.01 ± 
0.04% and 82.84 ± 9.24%, Fig. 2.9) respectively. Also, A1AR expression was downregulated 
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by ~17% in HS-fed A2AAR+/+ mouse (82.84 ± 9.24%) compared to NS-fed A2AAR+/+ mouse 
aortae (100.0 ± 0.04%, p<0.05; Fig. 2.9).  
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Fig. 2.1: a: NECA-induced vascular responses in aortic rings of A2AAR+/+ and A2AAR-/- mice 
fed NS and HS diet. Values are means ± SE. *p<0.05 between HS-A2AAR+/+ vs. NS-A2AAR+/+, 
$p<0.05 between HS-A2AAR+/+ vs. HS-A2AAR-/- , and #p<0.05 between NS-A2AAR+/+ vs. NS-
A2AAR-/-, n = 6. On the y-axis, postive and negative values represent relaxation and 
contraction, respectively. b: Effects of SCH 58261 (10-6 M) on NECA-induced vascular 
responses in aortic rings isolated from HS and NS fed mice. Values are means ± SE. *p<0.05 
between HS-A2AAR+/+ vs. NS-A2AAR+/+, $p<0.05 between HS-A2AAR+/+ vs. HS-A2AAR+/+ 
with SCH 58261, and #p<0.05 between NS-A2AAR+/+ vs. NS-A2AAR+/+ with SCH 58261, n = 
6. 
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Fig. 2.2: a: CGS 21680-induced vascular responses in aortic rings of A2AAR+/+ and A2AAR-/- 
mice fed NS and HS diet. Values are means ± SE. *p<0.05 between HS-A2AAR+/+ vs. NS-
A2AAR+/+, $p<0.05 between HS-A2AAR+/+ vs. HS-A2AAR-/-, and #p<0.05 between NS-
A2AAR+/+ vs. NS-A2AAR-/-, n = 6. b: Effects of 14,15-EEZE (10-5 M) on CGS 21680-induced 
vascular response in NS and HS fed A2AAR+/+ aortic rings. Values are mean ± SE. *p<0.05 
between HS-A2AAR+/+ vs. NS-A2AAR+/+, and $p<0.05 between HS-A2AAR+/+ vs. HS-
A2AAR+/+ with 14,15-EEZE, n = 6. 
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Fig. 2.3: a: Effects of DDMS (10-5 M) on NECA-induced vascular response in HS and NS fed 
A2A AR+/+ aortic rings. Values are mean ± SE. *p<0.05 between HS-A2AAR+/+ vs. NS-
A2AAR+/+, and #p<0.05 between NS-A2AAR+/+ vs. NS-A2AAR+/+ with DDMS, n = 4-6. b: 
Effects of DDMS (10-5 M) on NECA-induced vascular response in NS and HS fed A2AAR-/- 
aortic rings. Values are mean ± SE. #p<0.05 between NS-A2AAR-/- vs. NS-A2AAR-/- with 
DDMS, and $p<0.05 between HS-A2AAR-/- vs. HS-A2AAR-/- with DDMS, n = 4-6. 
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Fig. 2.4: a: Effects of DPCPX (10-5 M) on NECA-induced vascular response in NS and HS 
fed A2AAR+/+ aortic rings. Values are mean ± SE. #p<0.05 between NS-A2AAR+/+ vs. NS-
A2AAR+/+ with DPCPX, and *p<0.05 between HS-A2AAR+/+ vs. NS-A2AAR+/+, n = 4-6. b: 
Effects of DPCPX (10-5 M) on NECA-induced vascular response in NS and HS fed A2AAR-/- 
aortic rings. Values are mean ± SE. #p<0.05 between NS-A2AAR-/- vs. NS-A2AAR-/- with 
DDMS, and $p<0.05 between HS-A2AAR-/- vs. HS-A2AAR-/- with DDMS, n = 4-6. c: CCPA-
induced vascular response in aortic rings isolated from A2A AR+/+ and A2A AR-/- mice fed NS 
and HS containing diet. Values are means ± SE. *p<0.05 between HS-A2AAR+/+ vs. NS-
A2AAR+/+, and $p<0.05 between HS-A2AAR+/+ vs. HS-A2A AR-/- , and #p<0.05 between NS-
A2AAR+/+ vs. NS-A2AAR-/-, n = 4. 
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Fig. 2.5: a: Effects of DPCPX (10-7 M) on 20-HETE- induced vascular response in HS and 
NS fed A2A AR+/+ aortic rings. Values are mean ± SE, n = 3. b: Effects of DPCPX (10-7 M) on 
20-HETE-induced vascular response in NS and HS fed A2AAR-/- aortic rings. Values are mean 
± SE, n = 3. 
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Fig. 2.6: Representative Western-blot and densitometric analysis for A2AAR (~45 kDa) 
protein in aortae of HS and NS fed A2AAR+/+ mice. Values are mean ± SE, *p<0.05 between 
NS-A2AAR+/+ vs. HS-A2AAR+/+ mouse aortae, n=4. 
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Fig. 2.7: Representative Western-blot and densitometric analysis for cyp2c29 (~50 kDa) 
protein in aortas of HS and NS fed A2AAR+/+ and A2AAR-/- mice. Values are mean ± SE, 
*p<0.05 between HS-A2AAR+/+ vs. NS-A2AAR+/+, and $p<0.05 between HS-A2AAR+/+ vs. HS-
A2AAR-/-, n=4. 
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Fig. 2.8: Representative Western-blot and densitometric analysis for cyp4a (~50 kDa) protein 
in aortas of HS and NS fed A2AAR+/+ and A2AAR-/- mice. Values are mean ± SE, *p<0.05 
between HS-A2AAR+/+ vs. NS-A2AAR+/+, $p<0.05 between HS-A2AAR+/+ vs. HS-A2AAR-/-, and 
#p<0.05 between NS-A2AAR+/+ vs. NS -A2AAR-/-, n=4. 
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Fig. 2.9: Representative Western-blot and densitometric analysis for A1AR (~37 kDa) protein 
in aortae of HS and NS fed A2AAR+/+ and A2AAR-/- mice. Values are mean ± SE, *p<0.05 
between HS-A2AAR+/+ vs. NS-A2AAR+/+, $p<0.05 between HS-A2AAR+/+ vs. HS-A2AAR-/-, and 
#p<0.05 between NS-A2AAR+/+ vs. NS-A2AAR-/-, n=4. 
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Discussion: 
Our study utilized A2AAR+/+ and A2AAR-/- mice on a HS/NS diet to directly investigate 
functional and biochemical consequences of HS diet in the presence and absence of A2AAR. 
The major findings in this study show clear differences in vascular reactivity and signaling 
cascade between A2AAR+/+ and A2AAR-/- mice on a HS diet. Results from this study confirm 
that HS diet enhances vascular relaxation through increased A2AAR and cyp-epoxygenases 
pathway in A2AAR+/+ mice. Moreover, our novel findings suggest that HS diet potentiates 
contraction through reduced cyp-epoxygenases pathway and increased A1AR in A2AAR-/- mice. 
One of the interesting findings from our study demonstrates the contribution of 20-HETE in 
A1AR mediated contraction in NS fed. This suggests the involvement of different signaling 
mediators downstream of A1AR in vascular contraction observed in NS vs. HS fed A2AAR-/- 
mice. Hence, we speculate that HS diet in A2AAR-/- mice might induce some pathways 
downstream of A1AR other than 20-HETE to cause contraction that needs to be explored in 
future. 
Adenosine-induced vascular response in HS/NS-fed A2AAR+/+ and A2AAR-/- mice: 
As reported earlier by us (28) in mice and in rats pre-glomerular vessels (21-22), in A2AAR+/+ 
mice, we found enhanced relaxation to NECA  (Fig. 2.1a) which was blocked by selective 
A2A receptor antagonist, SCH 58261 and increased A2AAR protein levels with HS diet 
compared to NS diet (Fig. 2.6). However, HS exaggerated contraction to NECA in A2AAR-/- 
mice (Fig. 2.1a). Interestingly, we found no significant difference in contraction to NECA 
between NS-fed A2AAR-/- mice and HS-fed A2AAR-/- mice (Fig. 2.1a).  
Role of A2AAR and cyp-epoxygenases in vascular relaxation: 
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CGS 21680-induced aortic relaxation in HS/NS fed A2AAR+/+ mice were unaffected by 
cycloxygenase inhibitor, indomethacin and eNOS inhibitor, L-NAME (data not shown), 
indicating that HS-induced enhanced A2AAR-mediated vascular response is independent of 
COX and NO. However, EETs antagonist 14,15-EEZE, significantly blocked HS/NS-induced 
relaxation to CGS 21680. This finding is in agreement with our previous published work (28-
29) and others (6-7), and confirms the involvement of EETs in A2AAR-mediated enhanced 
vasodilatation in mice on HS/NS diet. Supporting the vascular response data, we found that 
HS diet increased levels of cyp2c29, the enzyme responsible for the production of 
vasodilatory EETs, compared to NS diet in A2AAR+/+ mice (Fig. 2.7). On the contrary, we 
observed substantially reduced expression of cyp2c29 in HS-fed A2AAR-/- mice compared to 
HS-fed A2AAR+/+ mice aortae, indicating that HS diet fails to up-regulate cy2c29 levels in the 
absence of A2AAR. Our data suggest that diminished cyp2c29 expression in HS-fed A2AAR-/- 
mice might account for the magnified contraction noted in these mice, possibly indicating an 
inability to efficiently adapt to HS in the absence of A2AAR. Dahl salt-sensitive rats are also 
unable to increase cyp-epoxygenase enzymes in response to HS diet which parallels our 
findings in HS-fed A2AAR-/- mice (21). 
 
Role of A1AR and cyp4a in vascular contraction: 
On the other hand, cyp4a enzyme catalyzes the metabolism of AA into 20-HETE, a potent 
vasoconstrictor. The NECA contraction response was blocked and transformed into relaxation 
by cyp4a inhibitor DDMS in NS-fed A2AAR+/+ mice (Fig. 2.3a), while it was significantly 
lowered in NS-fed A2AAR-/- mice, suggesting the role of 20-HETE in mediating vascular 
contraction. Compared to NS-fed A2AAR+/+ mice, NS-fed A2AAR-/- mice had substantially 
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increased expression of cyp4a possibly leading to increased generation of 20-HETE. However, 
DDMS did not affect the contraction observed in HS-fed A2AAR-/- mice, indicating that 20-
HETE might not be involved in HS-induced contraction noted in A2AAR-/- mice. We speculate 
that this discrepancy between the effects of DDMS in NS-fed A2AAR-/- mice and HS-fed 
A2AAR-/- mice could be due to different signaling mediators involved in these two groups and 
this finding needs to be further explored. Also, 20-HETE concentration-dependent vascular 
contraction was not blocked by DPCPX in NS/HS fed A2AAR-/- and A2AAR+/+mice (Fig. 2.5a 
and 2.5b). This indicates that 20-HETE is downstream of A1AR signaling. Western-blot 
analysis confirmed significantly suppressed levels of cyp4a in HS-fed A2AAR-/- mice 
compared to NS-fed A2AAR-/- mice possibly resulting in reduced production of 20-HETE with 
HS diet in A2AAR-/- mice (Fig. 2.8). This may contribute to enhanced relaxation with HS as a 
result of decreased 20-HETE production. Our data indicate that levels of vasodilator (cyp-
epoxygenase) and vasoconstrictor (ω-hydroxylase) agents appear to counterbalance each other 
thereby, maintaining vascular tone. Thus an imbalance in these vasoactive agents tends to 
disrupt this balance and lead to changes in vascular tone.  
 
Similar to our previous finding (29-30), we found HS diet decreased the expression of A1AR 
protein compared to NS diet fed A2AAR+/+ mice (Fig. 2.9). Lower levels of vasoconstrictor 
A1AR could probably aid in increased NECA-induced vascular relaxation in HS diet fed 
A2AAR+/+ mice. Since the role of A1AR in vascular contraction, and that of A2AAR in vascular 
relaxation are well established (28, 36), we examined the involvement of A1AR in NECA-
induced vascular response. Selective A1AR antagonist DPCPX blocked NECA-dependent 
contraction in NS-fed A2AAR+/+ mice and changed into a relaxation, suggesting the role of 
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A1AR. Furthermore, NECA-induced contraction in both the NS and HS-fed A2AAR-/- mice 
were mitigated by the selective A1 receptor antagonist, DPCPX, suggesting the contribution of 
A1AR in vascular contraction. In addition, Western-blot data showed higher expression of 
A1AR in both NS/HS diet fed A2AAR-/- mice compared to respective A2AAR+/+ mice. 
Nonetheless, compared to NS-fed A2AAR-/- mice, HS-fed A2AAR-/- mice displayed reduced 
A1AR levels. This is an interesting observation that implies that HS diet has a tendency to 
mitigate the level of A1AR but to a lesser degree in A2AAR-/- mice compared to A2AAR+/+ mice. 
 
A1AR-mediated vascular response in HS/NS-fed A2AAR+/+ and A2AAR-/- mice: 
To further examine the A1AR-mediated response in all the four groups, we used selective 
A1AR agonist CCPA and found that CCPA-dependent response produced significantly greater 
contraction in both the HS and NS-fed A2AAR-/- mice compared to their respective A2AAR+/+ 
mice. Corresponding to the A1AR levels, NS-fed A2AAR-/- mice demonstrated highest 
contraction to CCPA than HS-fed A2AAR-/- mice, suggesting that A1AR-mediated contraction 
is decreased with HS diet. Also, HS-fed A2AAR+/+ mice had the least contraction to CCPA 
compared to any other group, which corresponds well with the lowest observed level of A1AR 
in these mice compared to all groups. Overall, these results suggest that besides A2AAR up-
regulation, lowering A1AR expression might be another protective mechanism against salt 
loading. 
Conclusion: 
In conclusion, presence of A2AAR appears to be critical for an adaptive aortic relaxation 
response to HS intake (4-5 weeks). When the A2AAR is absent, HS diet fails to achieve 
relaxation response as observed in wild-type counterparts and produces amplified contraction 
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to NECA, possibly through diminished expression and activation of vasodilatory cyp-
epoxygenases pathway and enhancing the level and activity of vasoconstrictor factors like 
A1AR.  
Summary: 
Up-regulation of A2AAR and enhanced vascular relaxation through A2AAR in response to salt 
loading is most likely an adaptive response as shown in HS fed rat pre-glomerular vessels (21). 
This adaptive response is lost in the A2AAR null mice fed HS diet confirming a critical role of 
A2AAR in HS-induced vasodilation. NS and HS diet fed A2AAR-/- mice showed contraction to 
NECA. Although, the degree of contraction observed in A2AAR-/- mice fed NS diet is similar 
to A2AAR-/- mice fed HS diet, the mediators responsible for generating the vascular resistance 
seem to be different. For the most part, cyp4a and A1AR appear to be contributing to the 
contraction response in NS-fed A2AAR-/- mice. Conversely, it turns out that reduced cyp-
epoxygenases expression and activity along with increased A1AR levels might be playing an 
important role in the contraction response observed in HS-fed A2AAR-/- mice.  
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CHAPTER THREE: 
High salt diet modulates vascualr response in A2AAR+/+ and A2AAR-/- mice: Role of sEH, 
PPARγ, and KATP channels   
 
Abstract: 
Our previous study demonstrated that high salt (HS) diet produce enhanced vascular 
relaxation through adenosine A2A receptor (A2AAR) and cyp-epoxygenases-derived 
epoxyeicosatrienoic acid (EETs) whereas HS elicits exaggerated contraction in A2AAR-null 
mice. Downstream signaling mechanism contributing to the altered vascular reactivity through 
A2AAR in response to HS diet is not yet explored. This study aims to investigate the signaling 
mechanism involved in HS-induced modulation of vascular tone in the presence or absence of 
A2AAR. Therefore, we hypothesized that HS-induced A2AAR-EETs-mediated enhanced 
vascular relaxation is dependent on peroxisome-proliferator activated receptor-gamma 
(PPARγ) and ATP-sensitive potassium channels (KATP channels) in A2AAR+/+ mice, while, 
HS-induced vascular contraction to adenosine is mediated through increased soluble epoxide 
hydrolase (sEH) that degrades EETs in A2AAR-/- mice.  Organ-bath and Western-blot 
experiments were conducted in HS (4% NaCl) and normal salt (NS, 0.18% NaCl)-fed 
A2AAR+/+ and A2AAR-/- mice aortae. We found that enhanced vasodilation to A2AAR agonist, 
CGS 21680, in HS-fed A2AAR+/+ mice was blocked by PPARγ antagonist (T0070907) and 
KATP channel blocker (Glibenclamide). Also, sEH inhibitor (AUDA)-dependent vascular 
relaxation was mitigated by PPARγ antagonist, suggesting the role of PPARγ in EETs 
mediated vasodilation. PPARγ agonist (Rosiglitazone)-induced relaxation in HS-A2AAR+/+ 
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mice was attenuated by KATP channel blocker. These findings suggest that A2AAR-mediated 
enhanced vascular relaxation in A2AAR+/+ mice on a HS diet is dependent on EETs that act 
through PPARγ leading to opening of KATP channel downstream. On the other hand, HS-
induced contraction in A2AAR-/- mice was attenuated by sEH inhibitor. Also, higher levels of 
sEH were observed in A2AAR-/- mice compared to A2AAR+/+ mice on a HS diet. These data 
indicate that increased sEH expression contributes to the HS-elicited contraction in A2AAR-/- 
mice. Overall, finding from this study implicates the contribution of EETs, PPARγ and KATP 
channels downstream of A2AAR to mediate enhanced vascular relaxation in response to HS 
diet. In addition, higher sEH expression is found to play a key role in mediating vascular 
contraction in A2AAR-/- mice on a HS diet and sEH is identified as a potential target for 
improving adenosine-induced vascular contraction. 
Key Words: HS; NS; A2AAR; PPAR γ; EETs; KATP channel; relaxation; contraction. 
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Introduction: 
Adenosine, an endogenous nucleoside, is generally cytoprotective in nature and produced in 
response to stressful conditions. Adenosine mediates its effects via four adenosine receptors: 
A1, A2A, A2B, and A3 (14). Among many stressful conditions such as ischemia, hypoxia, injury 
and inflammation, exposure to high salt (HS) diet has also been shown to elevate the 
generation of adenosine (40, 51). Growing evidence suggests a link between high dietary salt 
intake and activation of adenosine receptors and A2A receptor in particular (26, 29, 31). In 
response to salt loading, enhanced vasodilation has been reported to occur through A2AAR (4, 
25-26, 29, 31).  
HS-induced A2AAR-mediated vasodilation is dependent on epoxyeicosatrienoic acid (EETs) 
generation through enhanced cyp-epoxygenase activity (6, 31-32). Studies from our lab and 
others have found that compared to NS, HS diet fed mouse aortae produced enhanced vascular 
relaxation to selective adenosine A2A receptor agonist (CGS-21680) and this enhanced 
dilation was blunted by cyp-epoxygenases inhibitor, methylsulfonyl-
propargyloxyphenylhexanamide (MSPPOH) (29), and also by EETs antagonist (14,15 EEZE) 
(36).  
EETs are 20-carbon fatty acid derived from the metabolism of arachidonic acid (AA) by 
cytochrome P450 epoxygenases (CYPs). The cellular levels of EETs depend not only on their 
production by CYPs but also on hydrolysis to dihydroxyeicosatrienoic acids (DHETs) by 
soluble epoxide hydrolase (sEH) (49). Inhibiting or deleting sEH has become an important 
approach to increase the level of EETs that cause reduction in blood pressure in mice (20, 39). 
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Many effects exerted by EETs overlap with adenosine function including regulation of 
vascular tone, inflammation, proliferation, platelet aggregation and cardiac function (15, 33, 
41). The receptors for EETs are, however, poorly understood. EETs receptors have not been 
identified and cloned yet and the mechanism by which EETs mediate their effects is largely 
unknown. However, there is some evidence suggesting that EETs act through receptors and 
some studies suggest that EETs have affinity to already known binding sites and receptors (9, 
44, 48). Report showing that EETs specifically binds to the plasma membrane of human U937 
transformed monocytes (44) indicates the presence of EETs receptor.  Given its pleiotropic 
effects, EETs may act through number of different receptors.  
Many of the longer-term actions of the epoxygenases pathways are common to PPARs 
activation. Activation of PPARs, similar to effect of EETs, causes regulation of vascular tone, 
vascular cell proliferation, migration and inflammation (7, 18). Proposed endogenous PPAR 
ligands have originated from AA and linoleic acid metabolism, among which possible ligands 
could be produced by epoxygenases pathway. Few studies have been conducted to examine 
the possible candidacy of epoxygenase-derived metabolites as PPAR ligands. Cyp4a 
metabolite of EETs has been reported to be high affinity PPAR ligands (8, 13). Also, EETs 
protects against angII-induced abdominal aneurysm in cyp2j2-overexpressed mice through 
PPARγ (3).  In addition, EETs-induced angiogenesis in endothelial progenitor cells in patients 
with acute myocardial infarction is demonstrated to be dependent on PPARγ (46). Liu et al. 
(2005) reported that PPARγ antagonist (GW9662) blocked EETs/AUDA-mediated anti-
inflammatory effects (27), suggesting PPARγ is an effector of EETs.  The EETs-PPARγ 
pathway may therefore represent a novel endogenous pathway by which transitory lipid 
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mediators control vascular cell function. Henceforth, it would be interesting to evaluate the 
role of PPARγ on A2AAR-EETs mediated regulation of vascular tone in HS and NS fed mice. 
The peroxisome proliferator-activated receptors (PPARs) are ligand activated transcriptional 
factors belonging to the family of three (α, β/δ, γ) nuclear receptors that are activated by lipid 
metabolites and play a critical role in glucose homeostasis and lipid metabolism. PPARs have 
the ability to bind to large number of ligands mainly because of their large ligand-binding 
domain (34, 47). Accumulating evidence suggests that PPARγ contributes in regulation of 
vascular function and blood pressure in addition to its well-recognized role in adipogenesis 
and insulin sensitivity. Thiazolidinedione (TZD), specific PPARγ ligands, have been reported 
to lower blood pressure and provide cardiovascular benefits through regulating vascular 
function and vascular tone (37). Studies have demonstrated that PPARγ activation elicits 
relaxation in pulmonary arteries by activating KATP channels through unknown mechanism 
(23). 
It is interesting that activation of PPARγ, similar to effects of A2AAR and EETs, causes 
vasodilation, anti-inflammation and anti-proliferation. To our interest, it is evident that A2AAR 
and EETs are involved in HS-induced vascular relaxation, however, information regarding the 
role of PPARγ and KATP channels is lacking. Here in this study, the role of PPARγ and KATP 
channels in HS-induced A2AAR mediated vascular relaxation and the interplay between 
A2AAR, EETs, and sEH in the regulation of vascular tone is explored using HS and NS fed 
A2AAR+/+ and A2AAR-/- mice.   
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MATERIALS AND METHODS 
The experimental and animal care protocols used in this study were approved by the West 
Virginia University Institutional Animal Care and Use Committee and carried out according 
to the principles and guidelines of the Institute of Laboratory Animal Resources Guide for the 
Care and Use of Laboratory Animals. Ten-weeks-old inbred male and female CD-1 (A2AAR-/- 
and A2A AR+/+ mice) obtained from Dr. Ledent (Belgium), bred and maintained in our facility 
at West Virginia University were placed on a whole-grain diet containing either 0.18% NaCl, 
normal salt (NS) or 4% NaCl, high salt (HS) (TD88311 and TD92100 diets; Teklad, Madison, 
WI). The initial characterization of A2AAR+/+ and A2AAR-/- mice has been previously 
described by Ledent et al. (24).  In brief, to produce mice on a homogenous genetic 
background, first-generation heterozygotes were bred for 14 generations to mice on a CD-1 
(Charles River Laboratories) outbred background, with selection for the mutant A2AAR gene 
at each generation by PCR. Fourteenth generation heterozygotes were bred together to 
generate A2AAR+/+ and A2AAR-/- (1:1, their mate controls) mice (24).  All mice were studied 4-
5 weeks after assignment to either the NS or HS group. 
Isometric tension Muscle bath experiments: 
HS and NS fed A2AAR+/+ and A2AAR-/- mice were euthanized with pentobarbital sodium (100 
mg/kg, i.p.). The aorta was gently removed after thoracotomy, cleaned of fat and connective 
tissues, and cut transversely into rings of 3-4 mm in length as described previously by us (28-
29). Extreme care was taken not to damage the endothelium. The rings were mounted 
vertically between two stainless steel wire hooks. The two rings were suspended in 10 ml 
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organ baths containing modified Krebs-Henseleit buffer (in 118 mM of NaCl, 4.8 mM of KCl, 
1.2 mM of MgSO4, 1.2 mM of KH2PO4, 25 mM of NaHCO3, 11 mM of glucose, and 2.5 mM 
of CaCl2). The buffer was maintained around pH 7.4 at 37◦C. The aortic rings were 
equilibrated for 60 min with a resting force of 1 g as described previously by us (28-29). At 
the end of the equilibration period, tissues were contracted with KCl (50 mM) to check the 
viability. Aortic rings were then constricted with phenylephrine (PE, 10-6 M) and changes in 
tension were monitored continuously with a fixed range precision force transducer (TSD, 125 
C, BIOPAC system). Data were recorded using MP100 WSW, BIOPAC digital acquisition 
system and analyzed using Acknowledge 3.5.7 software (BIOPAC system). The vascular 
endothelium was tested to determine whether it was intact, as previously described by our 
laboratory (28-29) through acetylcholine (ACh, 10-6 M) on pre-contracted aortic rings with 
phenylephrine (PE). Preparations were then washed several times with Krebs-Henseleit buffer 
solution and allowed to equilibrate for 30 min before the experimental protocol began. For all 
tests, the contraction and relaxation responses are expressed as % decrease or % increase of 
PE-induced pre-contraction. 
 CGS 21680, AUDA and Rosiglitazone-induced vascular response in A2AAR+/+ and 
A2AAR-/- mice fed HS and NS diet:                                                                                                                               
The responsiveness of pre-contracted aortic rings from A2AAR+/+ and A2AAR-/- mice fed HS 
and NS diet to the selective sEH inhibitor, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid 
(AUDA), selective A2AAR agonist, 2-p-(2-carboxyethyl) phenethylamino-5′-N-
ethylcarboxamido adenosine hydrochloride (CGS 21680), or selective PPAR γ agonist, 
Rosiglitazone were obtained by cumulative addition of these drugs to the organ bath in 1-log 
increments to obtain a concentration-response curve (CRC) as previously described (28-29). 
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All concentration response determinations were run in parallel on pairs of rings from either 
HS (A2AAR+/+ and A2AAR-/-) or NS (A2AAR+/+ and A2AAR-/-). 
Effects of PPARγ antagonist on NECA, CGS 21680 and AUDA-induced vascular 
response in A2AAR+/+ and A2AAR-/- mice fed HS and NS diet: 
Selective PPAR γ antagonist (T0070907; 0.1 µM) was added 30 min before contraction of the 
tissue with PE and was present throughout the experiment. These experiments were performed 
in parallel on four rings from the same aorta with two serving as control and two treated with 
T0070907. 
Effects of sEH inhibitor on NECA-induced vascular response in A2AAR+/+ and A2AAR-/- 
mice fed HS and NS diet: 
Selective sEH inhibitor, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA; 10µM) was 
added 30 min before contraction of the tissue with PE and was present throughout the 
experiment. These experiments were performed in parallel on four rings from the same aorta 
with two serving as control and two treated with AUDA. 
Effects of KATP channel inhibitor and A2AAR antagonist on CGS 21680, Rosiglitazone-
induced vascular response in A2AAR+/+ and A2AAR-/- mice fed HS and NS: 
Selective KATP channel inhibitor, (Glibenclamide, 10 µM) and selective A2AAR antagonist 
(SCH-58261; 1 µM) was added 30 min before contraction of the tissue with PE, and was 
present throughout the experiment. These experiments were performed in parallel on four 
rings from the same aorta with two serving as control and two treated with Glibenclamide or 
SCH-58261. 
Western-blot analysis:  
  
80 
 
Aortae from HS and NS fed A2AAR+/+ and A2AAR-/- mice were isolated and each sample was 
homogenized with 130 µL RIPA buffer (Cell Signaling Technology Inc) on wet ice. The 
samples were transferred to dry ice for 5 min and then thawed on wet ice. After thawing, 
lysates were sonicated and the samples were vortexed and centrifuged for 5 min at 12,000 rpm 
at 4°C. Then, the supernatant was stored at –80°C. Protein was measured using Bio-Rad assay 
based on the Bradford dye procedure with bovine serum albumin (BSA) as a standard. The 
protein mixture was divided into aliquots and stored at –80°C. At the time of analysis, samples 
were thawed and 30 µg of total protein per lane was loaded on a slab gel. Proteins were 
separated by SDS-PAGE using 10% acrylamide gels (1-mm thick). After electrophoresis, the 
proteins on the gel were transferred to nitrocellulose membrane (Hybond-ECL) by 
electroelution. Protein transfer was confirmed by employing pre-stained molecular weight 
markers (Bio-Rad Laboratories, Hercules, CA). Following blocking with either 5% nonfat dry 
milk or BSA, the nitrocellulose membranes were incubated with primary antibodies for sEH 
and PPARγ (Santa Cruz Biotechnology, Santa Cruz, CA). 1:5000 primary antibody 
concentration was used for sEH antibody and 1:1000 primary antibody concentration was 
used for PPARγ antibody. β-actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was 
used as an internal control to normalize the target protein expression in each lane. The 
secondary antibody was a horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG. 
The membranes were developed using enhanced chemiluminescence (Amersham 
BioSciences) and exposed to X-ray film for the appropriate time. The data are presented as the 
ratio of target protein expression to β-actin.  
Chemicals, drugs & antibodies: Phenylephrine hydrochloride and acetylcholine chloride 
were dissolved in distilled water. NECA, CGS 21680, SCH-58261, Glibenclamide (Sigma 
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Chemicals, St. Louis, MO), Rosiglitazone (Cayman chemicals, Ann Arbor, MI) were 
dissolved in 100% DMSO as 10 mM stock solutions, which were followed by serial dilutions 
in distilled water. T0070907 (Cayman chemicals), AUDA (gift from Dr. Morisseau, UC 
Davis) were dissolved in DMSO. sEH (Santa Cruz Biotechnology) were used for Western-
blot experiments. 
Statistical Analysis: Statistical data are reported as mean ± SEM. One-way analysis of 
variance (ANOVA) was used to compare difference among groups, and two ways ANOVA 
for repeated measure, followed by Tukey post hoc test to compare the vascular responses to 
antagonist SCH-58261, Glibenclamide, AUDA, and T0070907. Differences were considered 
significant if p<0.05. Further, densitometry of Western-blot analysis (sEH) data was 
expressed as mean ± SEM in arbitrary units. All the statistical analyses were performed using 
Graph Pad Prism statistical package. 
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RESULTS: 
Effects of sEH inhibitor (AUDA) on NECA-dependent vascular response in HS and NS 
diet fed A2AAR+/+ and A2AAR-/- mice:  
HS–induced vascular response to NECA was significantly different in A2AAR+/+ vs. 
A2AAR-/- mice (p<0.05; Fig. 3.1a and Fig. 3.1b). HS diet enhanced relaxation (+17.34 ± 
2.50%) to NECA (10-6 M) in A2AAR+/+ mice compared to NS-diet whereas, HS-diet produced 
contraction (-56.77 ± 3.49%) to NECA in A2AAR-/- mice (P<0.05; Fig. 3.1a, Fig. 3.1b). 
Previous study from our lab has shown downregulation of cyp-epoxygenases enzyme that 
produce EETs in HS-fed A2AAR-/- mice (36). Hence, we examined if increase in EETs using 
sEH inhibitor could improve vascular response from contraction to relaxation in A2AAR-/- 
mice. AUDA significantly attenuated NECA (10-6 M)-dependent contraction (-56.77 ± 3.49% 
and -53.31 ± 7.27%) in HS and NS-fed A2AAR-/- mice, respectively to (-14.72 ± 3.24% and -
22.26 ± 3.63%; p<0.05; Fig 3.1b). These results suggest that pharmacological inhibition of 
sEH using AUDA to increase EETs availability can reverse vascular contraction to NECA in 
A2AAR-/- mice.  
Effects of PPARγ antagonist (T0070907) on CGS 21680, NECA and AUDA-dependent 
vascular response in HS and NS diet fed A2AAR+/+ and A2AAR-/- mice: 
            Selective A2AAR agonist, CGS 21680 demonstrated concentration-dependent 
vascular relaxation in both HS and NS-fed A2AAR+/+ mice with a significant difference 
(p<0.05; Fig 3.2a). HS-induced relaxation (+27.59 ± 3.04%) to CGS 21680 (10-6M) was 
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significantly diminished by PPARγ antagonist, T0070907 (10-7M), in A2AAR+/+ mice to 
(+10.60 ± 1.84%; p>0.05; Fig. 3.2a). However, relaxation response to CGS 21680 in NS-fed 
A2AAR+/+ mice (Fig. 3.2a) and contraction to NECA in NS/HS fed A2AAR-/- mice (Fig. 3.2b) 
were not affected by PPARγ antagonist. This indicates that HS-induced A2AAR mediated 
enhanced relaxation is dependent on PPARγ in A2AAR+/+ mice. 
We investigated the role of PPARγ in AUDA-induced vascular response in NS/HS-fed 
A2AAR+/+ and A2AAR-/- mice (Fig. 3.3). In Fig. 3.3, potent sEH inhibitor, AUDA produced 
greater concentration-dependent vascular relaxation (+4.14 ± 4.81% at 10-6 M; p<0.05) in HS-
fed A2AAR+/+ mice compared to NS-fed A2AAR+/+ mice (-3.94 ± 2.44%). Selective PPARγ 
antagonist, T0070907 (10-7M) completely blunted AUDA-dependent vascular response (from 
+4.14 ± 2.31% to -7.07± 2.98 % at 10-6 M; p<0.05) in HS-fed A2AAR+/+ mice (Fig. 3.3). No 
significant difference was noted with PPARγ antagonist in AUDA-induced response in NS-
fed A2AAR+/+ mice (Fig. 3.3). These data suggest that AUDA-induced relaxation in HS–fed 
A2AAR+/+ mice is dependent on PPARγ.  
Rosiglitazone-dependent vascular response in HS and NS diet fed A2AAR+/+ and A2AAR-/- 
mice: 
Selective PPARγ agonist, Rosiglitazone yielded concentration-dependent relaxation 
(+6.02 ± 2.60% at 10-6 M; p<0.05) in HS-fed A2AAR+/+ mice whereas contraction (-10.62 ± 
3.00%; 10-6 M) in NS-fed A2AAR+/+ mice (Fig. 3.4a).  On the other hand, Rosiglitazone (10-6 
M) produced significant contraction in NS and HS-fed A2AAR-/- mice (-14.49 ± 2.02% and -
18.47 ± 3.48%; Fig. 3.4a), respectively. This interesting finding implies that HS-induced 
relaxation to Rosiglitazone requires A2AAR, suggesting a link between A2AAR and PPARγ. 
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Effect of A2AAR antagonist (SCH 58261) on Rosiglitazone-dependent vascular response 
in HS and NS diet fed A2AAR+/+ and A2AAR-/- mice: 
To pharmacologically confirm if HS-induced relaxation to Rosiglitazone is dependent 
on A2AAR, we used selective A2A receptor antagonist, SCH 58261 for Rosiglitazone CRC (Fig. 
3.4b).  SCH 58261 (1 µM) changed (10-6 M) Rosiglitazone-dependent response from (-9.08 ± 
2.51% and +5.71 ± 3.73%) in NS and HS-fed A2AAR+/+ aortae to (-20.67 ± 2.81% and -10.53 
± 2.22%; p<0.05; Fig. 3.4b), respectively.  
Effects of KATP channels inhibitor (Glibenclamide) on CGS 21680 and Rosiglitazone-
dependent response in HS and NS diet fed A2AAR+/+ mice: 
         Since KATP channels is also involved in vasodilation (16), we investigated the role of 
KATP channels in CGS 21680 and Rosiglitazone-induced relaxation in NS and HS-fed 
A2AAR+/+ mice (Fig. 3.5, 3.6).  Relaxation to NECA (at 10-6 M) in HS-fed A2AAR+/+ mice was 
abolished by KATP channel inhibitor, Glibenclamide (10 µM), and the response changed from 
(+20.59 ± 2.87%) to (+4.47 ± 4.86%; p<0.05; Fig. 3.5). There was no change in CGS21680-
induced response in NS-fed A2AAR+/+ mice with or without Glibenclamide (Fig. 3.5). 
 Similarly, Glibenclamide also blocked Rosiglitazone-induced vascular relaxation in 
HS-fed A2AAR+/+ mice (from +3.50 ± 2.87% to -8.13 ± 1.78% at 10-6 M; p<0.05; Fig. 3.6), 
suggesting the role of KATP channels in Rosiglitazone-dependent relaxation. 
sEH protein expression in HS and NS-fed A2AAR+/+ and A2AAR-/- mice: 
  sEH (~62 kDa) protein expression observed in both NS-fed A2AAR-/- and HS-fed 
A2AAR-/- mice (133.10 ± 16.48% and 129.4 ± 7.29%) was ~33.1% and ~29% higher compared 
to their control counterparts NS and HS-fed A2AAR+/+ mouse aortae (99.96 ± 0.03% and 
110.20 ± 5.19%, Fig. 3.7) respectively.  
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FIGURES: 
 
 
Fig. 3.1: a: Effects of sEH inhibition with AUDA (10-5 M) on NECA-induced vascular 
responses in aortic rings isolated from HS and NS fed A2AAR+/+ mice. Values are means ± SE. 
*p<0.05 between HS-A2AAR+/+ vs. NS-A2AAR+/+, #p<0.05 between NS-A2AAR+/+ vs. NS-
A2AAR+/+ with AUDA, and $p<0.05 between HS-A2AAR+/+ vs. HS-A2AAR+/+ with AUDA, n 
=6. On the y-axis, positive and negative values represent relaxation and contraction, 
respectively. b: Effects of sEH inhibition AUDA (10-5 M) on NECA-induced vascular 
responses in aortic rings isolated from HS and NS fed A2AAR-/- mice. Values are means ± SE. 
#p<0.05 between NS-A2AAR-/- vs. NS-A2AAR-/- with AUDA, and $p<0.05 between HS-
A2AAR-/- vs. HS-A2AAR-/- with AUDA, n =6. 
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Fig. 3.2: a: Effects of PPARγ inhibition with T0070907 (10-7 M) on CGS-induced vascular 
response in HS and NS fed A2A AR+/+ aortic rings. Values are mean ± SE. *p<0.05 between 
HS-A2AAR+/+ vs. NS-A2AAR+/+, and $p<0.05 between HS-A2AAR+/+ vs. HS-A2AAR+/+ with 
T0070907, n =4-6. b: Effects of PPARγ inhibition with T0070907 (10-7 M) on NECA-induced 
vascular response in NS and HS fed A2AAR-/- aortic rings. Values are mean ± SE, n = 4-6. 
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Fig. 3.3: Effects of PPARγ inhibition with T0070907 (10-7 M) on sEH inhibitor (AUDA)-
induced vascular response in NS and HS fed A2AAR+/+ aortic rings. Values are mean ± SE. 
$p<0.05 between HS-A2AAR+/+ vs. HS-A2AAR+/+ with T0070907, and *p<0.05 between HS-
A2AAR+/+ vs. NS-A2AAR+/+, n = 6 
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Fig. 3.4: a: PPARγ activation with Rosiglitazone-mediated vascular responses in aortic rings 
of A2AAR+/+ and A2AAR-/- mice fed NS and HS diet. Values are means ± SE. *p<0.05 between 
HS-A2AAR+/+ vs. NS-A2AAR+/+, $p<0.05 between HS-A2AAR+/+ vs. HS-A2AAR-/-, and #p<0.05 
between NS-A2AAR+/+ vs. NS-A2AAR-/-, n = 6. b: Effects of A2AAR antagonist with SCH 
58261 (10-6 M) on Rosiglitazone-induced vascular response in NS and HS fed A2AAR+/+ 
aortic rings. Values are mean ± SE. *p<0.05 between HS-A2AAR+/+ vs. NS-A2AAR+/+, #p<0.05 
between NS-A2AAR-+/+ vs. NS-A2AAR+/+ with SCH 58261, and $p<0.05 between HS-
A2AAR+/+ vs. HS-A2AAR+/+-with SCH 58261, n =4-6. 
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Fig. 3.5: Effects of KATP channels inhibition with Glibenclamide (10-5 M) on CGS 21680-
induced vascular response in NS and HS fed A2AAR+/+ aortic rings. Values are mean ± SE. 
$p<0.05 between HS-A2AAR+/+ vs. HS-A2AAR+/+ with Glibenclamide, and *p<0.05 between 
HS-A2AAR+/+ vs. NS-A2AAR+/+, n = 4-6.  
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Fig. 3.6: Effects of KATP channels inhibition with Glibenclamide (10-5 M) on Rosiglitazone-
induced vascular response in NS and HS fed A2AAR+/+ aortic rings. Values are mean ± SE. 
$p<0.05 between HS-A2AAR+/+ vs. HS-A2AAR+/+ with Glibenclamide, and *p<0.05 between 
HS-A2AAR+/+ vs. NS-A2AAR+/+, n = 4-6.   
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Fig. 3.7: Representative Western-blot and densitometric analysis for sEH (~62 kDa) protein in 
aortas of HS and NS fed A2AAR+/+ and A2AAR-/- mice. Values are mean ± SE, $p<0.05 
between HS-A2AAR+/+ vs. HS-A2AAR-/-, and #p<0.05 between NS-A2AAR+/+ vs. NS -A2AAR-/-, 
n=4. 
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Discussion: 
Previously (36), we have reported a clear difference in vascular reactivity between A2AAR+/+ 
and A2AAR-/- mice on a HS diet; HS produced enhanced relaxation through A2AAR-EETs 
pathway in A2AAR+/+ mice whereas, contraction in A2AAR-/- mice. The present study has 
undertaken the investigation of underlying mechanism involved in HS-induced modulation of 
vascular tone in the presence and absence of A2AAR using A2AAR+/+ and A2AAR-/- mice fed 
HS/NS diet. The major findings in this study shed light upon the role of important mediators 
downstream of A2AAR and EETs in mediating HS-induced vascular reactivity in wild-type 
and A2AAR deficient mice. Results from this study identified PPARγ and KATP channels as 
key signaling mediators downstream of A2AAR-EETs pathway that contributes to enhanced 
vascular relaxation in HS-fed A2AAR+/+ mice. On the other hand, our result confirmed that HS 
diet potentiates contraction in A2AAR-/- mice through reduced generation of cyp-
epoxygenases-derived EETs and greater EETs hydrolysis as a result of increased sEH 
expression.  Most importantly, this study revealed significant reversal of the contraction in 
HS-A2AAR-/- mice by the use of sEH inhibitor in-vitro, and use of sEH inhibitor in-vivo needs 
to be further explored. Furthermore, interesting interactions between sEH and A2AAR-/- mice, 
and PPARγ and A2AAR has been elucidated in this study. 
Role of sEH inhibitor in NECA-induced vascular response in HS/NS-fed A2AAR+/+ and 
A2AAR-/- mice: 
sEH inhibitor, AUDA, increases or stabilizes the vasoactive EETs (19). HS produced greater 
relaxation to CGS 21680 compared to NS diet in A2AAR+/+ mice. We observed that AUDA 
enhanced vascular relaxation to CGS 21680 in NS-fed wild-type mice (Fig. 3.1a) to the level 
shown in HS-fed mice, suggesting that sEH inhibition causes higher relaxation through higher 
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EETs level; however there was no difference in vascular response to CGS 21680 in HS-fed 
A2AAR+/+ mice with AUDA as reported earlier by us (32). This may be due to EETs reaching 
the maximum effective capacity in HS-fed A2AAR+/+ mice, therefore, addition of sEH 
inhibitor, AUDA, did not affect further.  
Cyp-epoxygenases enzyme (cyp2c29) responsible for EETs production is demonstrated to be 
lower in A2AAR-/- mice on a HS diet (36) implying possible reduced availability of EETs in 
A2AAR deficient mice. Of note, studies have shown that reduced EETs can impair endothelial 
dilator response in obesity and diabetes (11, 50). In HS/NS-fed A2AAR-/- mice, AUDA was 
able to substantially reverse the NECA-induced vascular contraction (Fig. 3.1b), indicating 
beneficial use of sEH inhibitor in improving impaired vascular reactivity by elevating EETs in 
HS/NS-fed A2AAR-/- mice. Hence, it is logical that sEH inhibitor provides beneficial effects 
through elevating EETs which have vasodilatory and natriuretic properties. AUDA treatment 
has been reported to reduce ischemic infarct size in stroke-prone spontaneously hypertensive 
rats (10). Another sEH inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-
benzoic acid (t-AUCB) is shown to be protective against ischemia reperfusion injury (5). 
Moreover, Imig et al, 2005 demonstrated the blood pressure lowering effect in rats with salt-
sensitive hypertension and angiotensin II-induced hypertension (20-21).  Also, we observed 
higher sEH expression in A2AAR-/- mice compared to A2AAR+/+ mice on HS and NS diet (Fig. 
3.7) which further contributes to increased EETs conversion into diols (DHETs) in A2AAR 
null mice leading to lower EETs level. 
Role of PPAR γ in A2AAR-EETs-mediated vascular reactivity in HS/NS-fed A2AAR+/+ 
and A2AAR-/- mice: 
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A2AAR-mediated enhanced vascular relaxation in HS-fed A2AAR+/+ mice is dependent on 
EETs and EETs are shown to act on PPARγ (27). Therefore, we tested if A2AAR-elicited 
vascular relaxation is dependent on PPARγ. We found that PPARγ antagonist, T0070907, 
significantly blocked HS-induced relaxation to CGS 21680 (Fig. 3.2a), indicating the 
involvement of PPARγ downstream of A2AAR to produce enhanced vascular relaxation in 
mice in response to HS diet. This finding is in agreement with our previous published work 
(30) and others (27, 45) and confirms the contribution of PPARγ in A2AAR-mediated vascular 
response. 
AUDA concentration response curve indirectly represents EETs-dependent vascular response 
because sEH inhibition increases EETs level (46). AUDA-produced enhanced relaxation in 
HS-fed A2AAR+/+ mice compared to NS diet and this enhanced relaxation was blocked by 
PPARγ antagonist (Fig. 3.3) suggesting that EETs-mediated vascular relaxation is dependent 
on PPARγ. Altogether, from our results, it became evident that PPARγ contributes 
downstream of A2AAR and EET to produce greater vascular relaxation upon exposure to HS 
diet.                                                
PPAR γ-mediated vascualr response in HS/NS-fed A2AAR+/+ and A2AAR-/- mice: 
Consistent with the presence of PPARγ in vascular tissues, substantial evidence suggest the 
participation of PPARγ in regulation of vascular function and blood pressure (22). PPARγ 
activation is reported to increase blood flow via vasodilation (23, 38). We examined vascular 
response to PPARγ in HS and NS-fed A2AAR+/+ and A2AAR-/- mice using selective PPARγ 
agonist, Rosiglitazone. We found that Rosiglitazone produced significantly greater relaxation 
in HS compared to NS-fed A2AAR+/+ mice (Fig. 3.4a). Interestingly, Rosiglitazone produced 
concentration dependent response in both the HS and NS-fed A2AAR-/- mice compared to their 
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respective A2AAR+/+ mice (Fig. 3.4b), suggesting an interesting interaction between A2AAR 
and PPARγ. In agreement with our finding, He et al, 2013 also showed a positive feedback 
regulation between A2AAR and PPARγ to produce anti-inflammatory effects (17).  
Corresponding to Rosiglitazone response in A2AAR deficient mice, we found that 
pharmacological inhibition of A2AAR by using selective A2A receptor antagonist, SCH 58261 
also attenuated Rosiglitazone-induced relaxation in HS and contraction in NS-fed A2AAR+/+ 
mice, further validating the possible interaction between A2AAR and PPARγ. Overall, these 
results suggest that A2AAR might positively regulate PPARγ.   
Role of KATP channel in vascular response in HS/NS-fed A2AAR+/+ mice: 
Supporting the data published in earlier studies from our lab (35), we found HS-induced 
increased vascular relaxation to CGS 21680 is blocked by KATP channel inhibitor, 
Glibenclamide (Fig. 3.5), indicating the role of KATP channels in A2AAR-mediated vascular 
response. Also, PPARγ agonist, Rosiglitazone-elicited enhanced vascular relaxation was 
attenuated by Glibenclamide (Fig. 3.6), implicating the contribution of KATP channel in 
PPARγ-mediated vascular relaxation. Taken together, these data suggest that A2AAR-EETs-
PPARγ pathway produce vascular relaxation through KATP channel which is consistent with 
other report suggesting that PPARγ elicits relaxation in pulmonary arteries by activating KATP 
channels (23). 
PPARγ-dependent effects mostly occur through regulation of gene expression. However, 
these A2AAR-EETS-PPARγ-mediated changes in vascular tone through KATP channels are 
quick response that could not correlate with changes in gene expression that generally takes 
longer time. There is some evidence indicating that PPARγ-dependent alteration in vascular 
tone could occur through non-genetic pathway. Report also suggests that PPARγ activation 
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works through rapid phosphorylation or stimulation of ion channels that regulate vascular tone. 
In smooth muscle cells, PPARγ activation inhibit the L-type Ca2+ current (2), thereby 
reducing vascular contraction. TZDs may promote vascular relaxation through stimulation of 
kca channels; however, the mechanism remains unclear (12). In addition, Pioglitazone is 
shown to promote activation of myosin light chain phosphatase (1) and also inhibition of Rho 
kinase activity in vasculature (43).  Hence, A2AAR-EETs-mediated vascular relaxation via 
PPARγ may signal through activation of KATP channels and the mechanism of KATP channels 
opening by PPARγ needs to be further explored. 
Conclusion: The principle finding of this study identifies important signaling molecules 
invloved in HS-induced altered vascular reactivity to adenosine in the presence and absence of 
A2AAR. EETs, PPARγ and KATP channel are recognized as key downstream signaling 
molecules contributing to HS-induced A2AAR-mediated vascular relaxation while, increased 
sEH is identified as essential mediator involved in HS-elicited vascular contraction in A2AAR 
null mice. Most importantly, our data shed light on possible strategy to reverse HS-induced 
contraction to adenosine observed in A2AAR null mice by increasing the level of EETs 
through sEH inhibition. 
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CHAPTER FOUR: 
CONCLUSION, DISCUSSION AND FUTURE STUDIES 
 
CONCLUSION AND DISCUSSION: 
Excess salt intake is not only associated with salt-sensitive hypertension but also with 
cardiovascular morbidity and mortality (15).  Blood pressure response to HS diet is, however, 
heterogeneous which suggests that several other factors such as genetics, environment, age, 
and disease conditions are responsible for the pathophysiological effect of high salt intake. 
Salt intake is reported to interact with genetic polymorphisms for genes including angiotensin 
type I receptors, nitric oxide and aldosterone synthase (3, 24, 35). 
 Sodium sensitivity is usually studied in terms of BP changes but direct effects on vascular 
reactivity have been paid less attention. High salt diet has been linked with adenosine and 
adenosine mediated vascular reactivity. Studies from our laboratory and others have shown 
greater relaxation response to adenosine through A2AAR and EETs in rat pre-glomerular 
vessels and mouse aorta upon exposure to HS diet (30, 33). Few studies have provided an 
important insight into the possible role of A2AAR-EETs pathway in the pathogenesis of salt-
sensitive hypertension. When placed on a 7 days HS diet, Dahl salt sensitive rats develop SSH 
unlike Dahl Salt-resistant rats (29).  Dahl salt resistant rats show upregulation of A2AAR and 
cyp-epoxygenase enzyme that produce EETs resulting in exaggerated pre-glomerular 
vasodilation, whereas salt-sensitive rats do not (29). Makita et al. (32) demonstrated that HS 
diet by itself do not increase blood pressure but dietary salt intake do increase BP in rats upon 
the inhibition of epoxygenase with clotrimazole, thus rendering the rats salt-sensitive. This 
finding by Liclican et al, 2008 suggest that the inability to upregulate A2AAR and cyp-
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epoxygenases may probably result in high salt-induced hypertension (29). However, no direct 
evidence is available showing the potential functional outcome of HS diet on impaired 
vascular tone and the underlying mechanism involved in the absence of A2AAR. Therefore, to 
directly address the role of A2AAR and cyp-epoxygenase on HS-induced alteration of vascular 
tone, we utilized A2AAR+/+ and A2AAR-/- mice on a HS and NS diet in our first specific aim.  
Pharmacological studies are widely used to elucidate pathophysiological mechanism; however, 
they may lack specificity jeopardizing the explanation of results. Hence, use of specific gene 
manipulated technology has the potential to overcome this problem. Mice offer significant 
advantages over other animals because specific gene-manipulated technology has been 
developed in mice and used successfully as a powerful research tool. Here in this dissertation, 
for the first time, we have used A2AAR+/+ and A2AAR-/- mice on a HS and NS-diet to 
distinguish HS-induced vascular reactivity and underlying signaling mechanism in the 
presence and absence of A2AAR. Moreover, most of the studies carried out to investigate the 
contribution of A2AAR pathway under high salt condition employ short term dietary salt 
feeding protocol (7 days) that does not correlate to the habitual salt consumption. In this 
dissertation, we utilize four weeks salt feeding protocol that better reflect upon the habitual 
HS intake. 
 
Using isometric tension measurement studies, findings from this dissertation showed a clear 
difference in vascular reactivity and signaling mechanism between A2AAR+/+ and A2AAR-/- 
mice on a HS diet. Specifically, HS increased aortic relaxation in A2AAR+/+ mice, and EETs 
antagonist blocked adenosine-induced relaxation, suggesting that A2AAR mediated vascular 
relaxation to HS diet is dependent on EETs. Of relevance, these responses in conduit arteries 
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are similar to resistance arteries in pre-glomerular vessels (30). In addition, vasoconstrictor 
A1AR and cyp4a are observed to be lower in HS-fed A2AAR+/+ mice. On the other hand, HS 
increased aortic contraction in A2AAR-/- mice. Western blot analysis demonstrated that cyp-
epoxygenases which generate EETs, was significantly lower in A2AAR-/- mice compared to 
A2AAR+/+ mice on a HS diet. These data indicate that less EETs production contributes to the 
contraction to HS diet in the absence of A2AAR. Furthermore, we found that A1AR antagonist 
blocked HS-induced contraction to adenosine in A2AAR-/- mice and the expression of A1AR 
was higher in HS-fed A2AAR-/- mice compared to A2AAR+/+ mice. These findings signify the 
important role of A1AR in contraction observed in HS-fed A2AAR-/- mice. A1AR mediated 
contraction has been reported to occur through cyp4a by previous studies from our lab (23). 
Although the magnitude of contraction to adenosine in both NS and HS fed A2AAR-/- mice 
seems similar, cyp4a appears to be involved in A1AR-mediated contraction seen only in NS-
fed A2AAR-/- mice but not in HS-fed A2AAR-/- mice. This means that different mediators are 
responsible for producing contraction in HS and NS A2AAR-/- mice. Hence our result suggests 
that other than reduction in vasodilatory pathway involving EETs production through down-
regulated cyp-epoxygenases, augmentation of vasoconstrictor such as A1AR also seems to 
contribute to the contraction in HS diet fed A2AAR-/- mice.  
 It is likely that vasodilator (cyp-epoxygenases) and vasoconstrictor (ω-hydroxylase) 
counterbalance each other to maintain vascular tone. Thus, imbalance in the release of 
vasoactive agents can lead to change in the vascular tone. Taken together, finding from this 
study confirms that exposure to HS diet leads to activation of adaptive mechanism including 
stimulation of vasodilatory A2AAR and EETs pathway and suppression of vasoconstrictor 
A1AR pathway that entails enhancement of vascular relaxation. However, high dietary salt 
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intake fails to initiate the beneficial vasodilatory pathway in the absence of A2AAR leaving 
only with dominant vasoconstriction agents thereby, producing amplified contraction.  
Mounting evidence suggests that EETs act through receptors and some studies suggest that 
EETs have affinity to already known binding sites and receptors (11, 44, 46). Nonetheless, 
EETs receptors have not been identified and cloned yet and the mechanism by which EETs 
mediate their effects is largely unknown. Our first aim confirmed that HS diet produce 
vascular relaxation through A2AAR and cyp-epoxygenase derived EETs. But the downstream 
signaling mechanism by which vascular relaxation is produced in response to HS diet is not 
known. We addressed this question in our second aim. Many of the long-term actions of the 
epoxygenase pathways are common to PPARs activation. Activation of PPARs, similar to the 
effect of EETs, causes regulation of vascular tone and inhibition of vascular cell proliferation, 
migration and inflammation. Some studies showed that shear stress-induced EETs generation 
by endothelial cells is shown to have paracrine anti-inflammatory effect through inhibition of 
NFκB by activating PPARγ (31), implying that EETs are the effector of PPARγ. Whether 
A2AAR-elicited EETs act through PPARγ to produce vasodilation during salt loading is not 
yet explored. In our second aim, we investigated the contribution of PPARγ in vascular 
reactivity to adenosine using A2AAR+/+ and A2AAR-/- mice on a HS diet. We found that HS-
induced greater relaxation through A2AAR is blocked by PPARγ antagonist in A2AAR+/+ mice 
suggesting that A2AAR-mediated vascular relaxation through EETs is dependent on PPARγ. 
Hence, these findings indicate that PPARγ is involved in enhanced vascular relaxation to 
adenosine during salt loading possibly by being activated by EETs.  
EETs have an anti-pressor effect during salt loading (7, 32) owing to its potent vasodilator and 
natriuretic properties (6). However, EETs are short-lived lipids that are readily metabolized by 
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an enzyme sEH. sEH activity is implicated in hypertensive animal model and vasoconstriction 
(19). Our lab has previously shown lower sEH expression with HS diet that may partly 
contribute to increased vasodilation in these mice (34). Nonetheless, the interaction between 
sEH and HS diet in A2AAR deficient mice has not been explored yet. In second aim of this 
dissertation, we examined the role of sEH in relation to A2AAR deficiency-mediated change in 
vascular reactivity in HS fed mice. Western blot studies showed increased expression of sEH 
in A2AAR deficient mice on a HS diet compared to wild type mice. sEH inhibition is expected 
to increase bioavailability of EETs (45), which has beneficial cardiovascular effects (8, 10, 
18). In our experiment, sEH inhibitor attenuated the amplified contraction to adenosine in HS 
and NS-fed A2AAR-/- mice, suggesting that increased accumulation of EETs through sEH 
inhibition can improve the vascular reactivity in A2AAR deficient mice. This further support 
our finding from specific aim one that less EETs level due to its decreased production through 
A2AAR and its increased degradation by sEH might contribute to enhanced contraction to 
adenosine in A2AAR-/- mice. 
EETs accumulation can be achieved by inhibition of sEH that degrades EETs (47). We used 
AUDA, sEH inhibitor, to study EETs dependent responses. In agreement with our finding 
mentioned earlier, we found that AUDA-dependent vascular relaxation in HS-fed A2AAR+/+ 
mice was significantly attenuated by PPARγ antagonist, which further confirms the role of 
PPARγ in EETs-mediated vasodilation. PPARγ-dependent effects mostly occur through 
regulation of gene expression. However, these changes in vascular tone are quick response 
that could not correlate with changes in gene expression that generally takes longer time. 
Hence, PPARγ-dependent changes in vascular tone may happen through non-transcriptional 
pathway. There is little evidence suggesting that PPARγ activation works through rapid 
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phosphorylation or stimulation of ion channels that regulate vascular tone. In smooth muscle 
cells, PPARγ activation inhibit the L-type Ca2+ current (4), thereby reducing vascular 
contraction. TZDs may promote vascular relaxation through stimulation of KCa channels; 
however, the mechanism remains unclear (14). In addition, Pioglitazone is shown to promote 
activation of myosin light chain phosphatase (2) and also inhibition of Rho kinase activity in 
vasculature (43). 
In second aim, we also examined the role of KATP channel, as previous studies from our lab 
have suggested the contribution of KATP channel in A2AAR-dependent vascular relaxation (34, 
37). We found that increased vascular relaxation through A2AAR is blocked by KATP channel 
inhibitor in HS-fed A2AAR+/+ mice indicating that A2AAR-mediated vasodilation is dependent 
on KATP channel. In addition, vascular relaxation to PPARγ agonist is also attenuated by 
inhibition of KATP channels further corroborating the role of KATP channel in mediating 
vasodilation to adenosine signaling through PPARγ. 
Direct interaction between adenosine and PPARγ has not been studied well. We used 
A2AAR+/+ and A2AAR-/- mice on HS and NS diet to directly evaluate the link between A2AAR 
and PPARγ. We observed that PPARγ agonist produced relaxation in HS-fed A2AAR+/+ mice 
but not in A2AAR-/- mice on a HS or NS diet. Also, the relaxation to PPARγ agonist was 
blocked by A2AAR antagonist thus, pharmacologically confirming the result observed in 
transgenic mice. In agreement with our result, recent finding by He et al. (17) also 
demonstrated increase in expression and activation of PPARs with A2AAR activation. 
Altogether, A2AAR seem to positively regulate PPARγ.  
Interestingly, vascular reactivity to adenosine in mouse aortae observed in our studies closely 
correlate with rat pre-glomerular microvessels on a HS diet. In both the mouse aortae and rat 
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pre-glomerular vessels, HS-induced adenosine-mediated exaggerated vasodilation is found to 
occur through A2AAR and EETs (30, 33, 38). These findings provide strong support for the 
argument that aortic responses and A2AAR signaling mechanisms might be similar to resistant 
renal arteries upon salt loading. Based on these observations, we can argue that these changes 
in vascular tone in response to HS diet could be a systemic phenomenon.  
Vascular reactivity alteration in response to excess salt intake may be initial adjustment in 
case of augmented relaxation in the presence of A2AAR or early deleterious changes that have 
harmful cardiovascular consequences in case of vascular contraction in the absence of A2AAR. 
In agreement with our study, other evidence has shown altered vascular function and wall 
composition in response to NaCl (12). In genetic model of rat hypertension, increased sodium 
intake is associated with specific alteration of structure and function of conduit arteries 
independent of BP and atherosclerosis (39). Therefore, alteration in vascular reactivity such as 
marked decrease in vascular tone may serve as a marker for deleterious effects that occurs 
either in advance of rise in BP or following increased BP. Our study has revealed the prospect 
to improve adenosine-mediated vascular contraction in A2AAR deficient mice through sEH 
inhibition, suggesting that sEH could be a potential therapeutic target for the management of 
salt-induced altered vascular reactivity to adenosine.  
 
Therefore, results from this dissertation have contributed to advance the existing knowledge in 
high salt-induced alteration in adenosine-mediated vascular reactivity in the presence and 
absence of A2AAR and the underlying signaling mechanism involved. This study not only 
provide better understanding of the role of A2AAR-EETs-PPAR γ, KATP channels and sEH on 
HS-induced changes in vascular reactivity but also suggest sEH as a potential targets for 
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developing novel therapeutic strategies (sEH inhibitor) for improving impaired vascular 
reactivity during salt loading. Polymorphism in A2AAR (1, 25, 41) and cyp-epoxygenase ((9, 
13, 20-21, 36, 41-42) has been found and has been associated with cardiovascular disorders 
including hypertension. Also, genetic polymorphism in sEH has been found in human 
population with risk of coronary heart disease, ischemic stroke, restenosis, diabetes, and heart 
failure (5, 13, 16, 22, 27). Also differential renal sEH gene expression has been observed in 
pre-hypertensive, hypertensive and spontaneously hypertensive rats (40). High salt diet itself 
may not have profound deleterious effects; however, HS diet combined with faulty gene could 
produce significant noticeable adverse effects. Hence, this study might also help explain the 
heterogeneity in BP response to HS diet, and the interaction between environmental factors 
(HS diet) and genetic factors such as defective A2AAR gene, cyp-epoxygenase gene or sEH 
gene leading to vascular abnormality. 
 
Summary: 
The principle finding of this dissertation project elucidates the indispensable role of adenosine 
A2A receptor signaling in producing adaptive aortic relaxation during salt loading, which is 
lost in the A2AAR deficient mice. Furthermore, work presented in this dissertation identifies 
important signaling molecules involved in HS-induced altered vascular reactivity to adenosine 
in the presence and absence of A2AAR. EETs, PPARγ and KATP channels are recognized as 
key downstream signaling molecules contributing to HS-induced A2AAR-mediated vascular 
relaxation; while, increased A1AR and sEH and lower cyp-epoxygenases activity are 
identified as essential mediators involved in HS-elicited vascular contraction in A2AAR-null 
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mice. Most importantly, this dissertation uncovers the potential of sEH inhibitor to reverse the 
vascular contraction in A2AAR deficient mice as a result of increased level of EETs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 4.1: Summary Figure: Schematic diagram showing vascular response and signaling 
pathway in HS-fed A2AAR+/+
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 vs. A2AAR-/- mice. 
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Future Studies: 
This dissertation has clearly demonstrated the significant difference in aortic reactivity and 
signaling mechanism between A2AAR+/+ and A2AAR-/- mice on a HS diet.  
Although, we observed changes in vascular tone to adenosine upon HS diet in the presence 
and absence of A2AAR, whether these vascular alteration occurs prior to BP changes or lead to 
rise in blood pressure are not explored. A2AAR deficient mice are reported to have high BP 
(26).  Therefore, it is important to investigate BP in HS and NS-fed A2AAR+/+ and A2AAR-/- 
mice in future in order to determine if altered vascular reactivity to HS diet is dependent or 
independent of BP changes.  
Regulation of blood pressure can be achieved by regulating vascular tone; however, this is 
particularly true for resistance arteries compared to conduit arteries. Renal arteries play a 
critical role in regulating blood pressure during salt loading. We have observed similar 
response of A2AAR-mediated vascular tone in both mouse aortae and rat PGMVs; thus, it will 
be interesting to further investigate vascular reactivity in other resistant arteries as well in 
future to determine if these changes in adenosine-elicited vascular tone under HS condition 
are systemic phenomenon. 
Duration of exposure to HS diet varies tremendously among individuals and research 
experiments. Four weeks of HS diet is typically considered moderately long-term in rodents 
(28). With four weeks of HS diet, we found significant differences between A2AAR+/+ and 
A2AAR-/- mice in terms of vascular tone. It is possible that these alterations in vascular 
reactivity represent earlier modifications prior to changes in BP. Thus, further investigation of 
even longer-term exposure to HS diet involving 2-3 months of salt feeding may help to better 
understand the chronic effects of HS diet in terms of vascular reactivity and BP. 
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From our result, we also determined the cause of exaggerated vascular contraction in A2AAR-/- 
mice on a HS diet as decreased level of EETs due to its blunted production through lower cyp-
epoxygenases and its increased degradation by sEH. Most importantly, we found that sEH 
inhibitor was able to reverse the contraction in HS-fed A2AAR-/- mice ex vivo. Further 
evaluation is required to determine if administration of sEH inhibitor in vivo will show the 
same effect on HS-induced vascular reactivity and BP.  
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Appendix A: 
 
Preliminary experiments were carried out to determine the effects of Indomethacin (10-5 M) 
on CGS 21680-induced vascular response in NS and HS fed A2AAR+/+ aortic rings. No 
difference was found with or without Indomethacin in CGS-21680-induced vascular response 
in NS and HS fed A2AAR+/+ aortic rings, n = 6. 
 
CGS concentration response curve in NS and HS A2AAR+/+ mice with or without 
cyloxygenase inhibitor (Indomethacin) 
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Preliminary experiments were carried out to determine the effects of L-NAME (10-5 M) on 
CGS 21680-induced vascular response in NS and HS fed A2AAR+/+ aortic rings. No difference 
was found with or without L-NAME in CGS-21680-induced vascular response in NS and HS 
fed A2AAR+/+ aortic rings, n = 6. 
 
CGS 21680 concentration response curve in NS and HS A2AAR+/+ mice with or without e-
nos inhibitor (L-NAME) 
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Appendix B: 
 
Preliminary experiments were carried out to determine acetylcholine-induced vascular 
response in NS and HS-fed A2AAR+/+ and A2AAR-/- aortic rings. Compared to NS-fed 
A2AAR+/+ mice, acetylcholine-induced relaxation is significantly lower in all the three groups 
including HS-fed A2AAR+/+ mice, and NS and HS-fed A2AAR-/- mice. Data are expressed as 
Mean± SEM, *p<0.05 between HS-A2AAR+/+ vs. NS-A2AAR+/+, and #p<0.05 between NS-
A2AAR+/+ vs. NS-A2AAR-/-, n = 6 
 
 
Acetylcholine concentration response curve in NS and HS A2AAR+/+ and A2AAR-/- mice 
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